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ABSTRACT
The ability of bacteria to sense and adapt to environmental changes has allowed these organisms to thrive in all parts of the globe and to establish many complex interactions with the environments in which they live as well as with other
members of these environments. Crucial to monitoring extracellular conditions is a
group of signaling pathways known as two-component signal transduction systems
(2CST). These systems relay information from the extracellular environment to the
interior of the cell via a transfer of phosphoryl groups from the sensory protein
known as a sensor kinase (SK) to the output protein known as a response regulator
(RR).
In addition to this constant input of extracellular information, bacterial cells
also monitor their intracellular environment, as among other things, it provides precious information about their nutritional status. It is the integration of these extracellular and intracellular cues that will determine which genes should be transcribed, assuring the most appropriate response for each environment at any given
time.
Here, I present evidence that one of these 2CST systems in E. coli, the CpxAR
system, integrates signals originated from both the extracellular environment and
from central metabolic pathways to modulate transcription of the CpxR-dependent
xi

gene cpxP. Through a series of genetic and biochemical experiments I demonstrate
that acetyl-phosphate (AcP), a central metabolite originated from the Pta-AckA
pathway, donates its phosphoryl group to the RR CpxR both in vitro and in vivo and
that this transfer of phosphoryl group activates cpxP transcription.
In addition to CpxR phosphorylation, my data suggest that cpxP transcription
is also sensitive to an additional posttranslational modification, Nε-lysine acetylation
of RNA polymerase (RNAP). My data implicate the acetylation of two lysine side
chains on the carboxyl terminal domain of the α subunit (αCTD) of RNAP in the
modulation of cpxP transcription in response to the AcP-dependent phosphorylation
of CpxR. Together, CpxR phosphorylation and the acetylation of Lys-298 on αCTD
contribute to transcriptional activation of cpxP, whereas acetylation of Lys-291
dampens this response. Thus, protein phosphorylation and protein acetylation,
seem to act together to fine-tune cpxP transcription.

xii

CHAPTER ONE
INTRODUCTION
Bacteria are ubiquitous organisms. Their wide spread prevalence plays an
important role in the diverse environments they inhabit. In the soil, bacteria are key
contributors to the nitrogen cycle, and different steps of this cycle are carried out by
different groups of bacteria [reviewed in (15)]. In the ocean, bioluminescent bacteria are thought to help the Hawaiian bobtail squid escape predation by providing
light that the squid uses to counter illuminate its shadow [reviewed in (62)]. In
mammals, gut bacteria have been shown to contribute to host metabolism, potentially contributing to obesity and diabetes (13, 134). The complex and diverse microbiota in the human gut has been shown to interact with several branches of the
immune system, influencing gut barrier and defense mechanisms. It is thought that
these interactions influence immune homeostasis and that an imbalance in this homeostasis could contribute to autoimmune diseases (22, 65). Additionally, the human intestinal microbiota is thought to play an important role in preventing the establishment of opportunistic infection by preventing the establishment of invading
species and/or by helping control the number of some potentially harmful members
of the community (3).
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These different interactions with their environment are the result of many
years of coevolution (105), resulting in an intricate and sophisticated interaction
among the different species involved. These interactions often require that different
organisms can sense each other and their environment, and that they can quickly
respond to changing conditions, assuring that the most appropriate genes and proteins are transcribed and synthesized at the precise amount at any given time.
To sense changes to the extracellular environment, bacteria commonly use
sensory systems known as two-component signal transduction (2CST) pathways. As
the name implies, the simplest of these pathways consists of only two components: a
sensor kinase (SK) and a response regulator (RR) (Fig.1 Left). The SK is a histidine
kinase that autophosphorylates a conserved histidine (His) residue using ATP as its
phosphoryl donor. Once phosphorylated, the SK serves as the phosphoryl donor to
its cognate RR, an aspartyl kinase that autophosphorylates a conserved aspartate
(Asp) residue located in its receiver domain [reviewed in (127)]. In general, the
more complex the environment in which a bacterial species lives, the greater the
number of 2CST pathways encoded by its genome (16).
In addition to constantly monitoring their extracellular environment, bacteria must also closely monitor their intracellular environment, as such monitoring
provides important information concerning nutritional status. This nutritional information allows a bacterial cell to ‘decide’ how much energy it can invest in different physiological processes and ultimately decide whether the cell should remain
metabolically active or become quiescent (61).
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The cells can receive cues concerning their nutritional status by monitoring
the ratios and/or concentrations of important molecules, such as NAD+/NADH,
ATP/ADP, cAMP and ppGpp. The information obtained from the ratios and/or concentrations of these different molecules must be integrated with signals that are being received from the extracellular environment. Proper signal integration should
promote the most adequate amount of expression and activity of the proteins most
suited for survival at that specific environmental condition. One of the many ways
by which bacterial cells can integrate large amounts of constant and diverse sensory
information is posttranslational modification of proteins, especially of proteins involved in signal transduction and proteins involved in the transcriptional machinery
that convert the signal into action.
My dissertation focuses on the mechanism by which one signaling pathway
of Escherichia coli, the CpxAR 2CST system, integrates intracellular cues to regulate
the cpxP promoter, which drives expression of a chaperone that respond to
periplasmic stresses, such as unfolded proteins. The data I will provide here supports a model in which the CpxAR pathway utilizes intracellular information to
modulate cpxP transcription via an acetylphosphate (AcP)-dependent phosphorylation of the RR CpxR and AcP-dependent acetylation of RNA polymerase (RNAP).
During the next few pages, I will provide a brief overview of 2CST and the
CpxAR pathway. I will then provide some background information on AcP and Acetyl-Coenzyme A (AcCoA), followed by an overview of the current understanding of
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protein acetylation. I will end with an explanation of RNAP and the steps involved in
transcription initiation.

TWO-COMPONENT PATHWAYS
Two-component signal transduction (2CST) pathways are sophisticated sensory systems found in bacteria, archaea and a few eukaryotic organisms (127).
These systems help organisms sense and mount a response to changes in their environment. The classic 2CST pathway contains only two proteins, a sensor kinase protein (SK) and a cognate response regulator (RR) (Fig. 1 left). The SK is often but not
always integral to or associated with the cellular membrane (12). The RR is often
but not always involved in transcriptional regulation and thus often but not always
will contain a DNA-binding domain (41, 42). 2CST proteins are modular and, in general, RRs possess two independent domains while SKs contain two highly conserved
domains, a dimerization and histidine phosphotransfer (DHp) domain and the catalytic and ATP binding (CA) domain, and at least one and sometimes several additional domains (40). 2CST pathways also can be made of more than two proteins
(Fig. 1 right), adding complexity to the transfer of information from the SK to the
RR as it increases the number of domains and/or proteins that are involved in the
signal transduction; thus, increasing the number of places on the pathway in which
the transfer of information can be regulated (12). For the purpose of this dissertation, henceforth, I will focus on the less complex and more orthodox form of these
2CST pathways.
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Many organisms encode multiple 2CST that are involved in sensing different
environmental signals. In general, 2CST pathways share a large degree of homology
among each other. Thus, many mechanisms are in place to prevent an erroneous
transduction of signal between non-cognate 2CST pathways, also known as crosstalk. In order to achieve this specificity, cognate SKs and RRs are thought to have coevolved to incorporate specificity residues along the surface or regions used for
their interaction. These residues decrease the rate of phosphoryl transfer among
non-cognate proteins, while maintaining a high transfer rate among cognate proteins [reviewed in (100)].
The relay of information from the SK to the RR, leading to the final output,
requires multiple phosphoryl transfers. It initiates with the transfer of phosphoryl
groups from the γ phosphoryl group of ATP to a conserved His side chain on the SK.
This transfer of phosphoryl group from ATP to the conserved His side chain of the
SK is mediated by conserved residues on the ATP-binding domain of the SK. Once
phosphorylated, the phosphorylated SK serves as the phosphoryl donor to its cognate RR, which autocatalyzes the phosphorylation of a conserved Asp side chain on
the surface of its own receiver domain. This phosphotransfer from the SK to the RR
requires divalent metal ions and Mg2+ is thought to be the prevalent cation used in
vivo. Phosphorylation of the conserved Asp residue leads to a conformational
change in the RR, allowing it to alter the molecular interaction(s) by which the response is achieved. The final phosphotransfer occurs from the phosphorylated Asp
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to water via hydrolysis, bringing the RR back to its unphosphorylated
state[reviewed in (127)].
The half-life of phosphorylated RRs vary drastically, but typically ranges
from a few second to hours (51). However, there are some exceptions. For example,
the yeast response regulator SSK1 has a half-life of approximately 2 days (59). Several factors contribute to this short half-life: (i) phospho-Asp possesses an intrinsic
instability which favors its unphosphorylated state (1); (ii) many RRs possess autophosphatase activity, which helps increase the rate of dephosphorylation (51); and
(iii) Many SKs also contain phospho-Asp phosphatase activity, which is also thought
to contribute to the dephosphorylation rate of their cognate RRs [reviewed in (43,
74)]. This phospho-Asp phosphatase activity has been demonstrated both in vivo
and in vitro for many SK. However, in some cases, it has been proposed that the
phosphatase rate is too slow for it to be relevant in vivo (66).

THE CpxAR TWO-COMPONENT SIGNAL PATHWAY
The E. coli K-12 genome encodes 30 SKs and 32 RRs (93). The RR CpxR and
its cognate SK CpxA constitute the 2CST pathway CpxAR (Fig. 2). This signal pathway is highly conserved in the family Enterobacteriaceae and can be found in some
other Proteobacteria. In E. coli, the CpxAR pathway regulates transcription of at
least 50 genes (29, 102), including genes that control part of the envelope stress response system, pilus assembly, type III secretion, motility and chemotaxis, adherence, and biofilm development. Furthermore, the CpxAR pathway is required for in-
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vasion of host cells in diverse pathogenic bacteria, including E. coli (enterohemorrhagic E. coli and uropathogenic E. coli), Salmonella enterica serovar Typhimurium,
S. enterica serovar Typhi, Shigella sonnei, Yersinia enterocolitica, Heamophilus ducreyi and Legionella pneumophila [for reviews, see references (31, 32, 106, 109, 110,
115, 122)]. A recent study demonstrated that Xenorhabdus nematophilus requires
the Cpx pathway both to colonize its nematode host (Steinernema carpocapsae) and
to kill larvae of the tobacco hornworm (Manduca sexta). In L. pneumophila, the
pathway regulates the type IV bundle-forming pilus (BFP) and some components of
type IV secretion, respectively [reviewed in (137)]. BFP assembly is also affected by
the CpxAR system in enteropathogenic E. coli (EPEC). In this organism, a deletion of
CpxR decreased BFP and affected its ability to adhere to epithelial cells (97).
The CpxAR is an autogenously regulated 2CST pathway. CpxA, a SK with autokinase, phosphotransfer, and phospho-CpxR phosphatase activities (36, 111), is
located in the cytoplasmic membrane, where it senses diverse signals, including alkaline pH, altered membrane lipid composition, interaction with hydrophobic surfaces, and misfolded pilin subunits, as well as exposure to copper, detergents, and
EDTA. In response to these different stimuli, CpxA autophosphorylates and serves as
a donor of phosphoryl groups to CpxR, the cognate RR. By analogy to the RR OmpR,
CpxR phosphorylation is thought to occur on the conserved Asp-51 residue on its
receiver domain.
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The CpxR pathway includes at least two more upstream components. The
first additional component, CpxP, was identified as an alkaline-induced member of
the Cpx regulon (23). This periplasmic chaperone binds to the periplasmic domain
of CpxA and inhibits its autokinase activity (36, 107, 108). It appears that CpxP
binds to specific features of certain misfolded proteins, making them available to the
ATP-independent periplasmic protease DegP. Since CpxP is degraded along with its
cargo, misfolded proteins in the periplasm enhance the probability that CpxA will
function as a kinase and initiate the phosphotransfers that will end with activation
of the Cpx regulon including CpxP (11, 30, 54, 77). The second component, the outer
membrane lipoprotein NlpE, activates CpxA when it is overexpressed (120), and it is
required for activation of CpxA in response to adherence to hydrophobic surfaces
(98). Since adhesion requires NlpE, but not CpxP, and since stresses that require
CpxP do not require NlpE (23, 30, 98), CpxA must integrate information from at
least these two distinct stress response pathways (30, 107). Furthermore, it is likely
that additional upstream components exist (107). For example, CpxA and CpxRdependent resistance to copper exposure requires neither CpxP nor NlpE (151).
In the absence of its extracytoplasmic stimuli, CpxA is reported to function as a net
phosphatase, removing phosphoryl groups from phospho-CpxR (85, 111, 149). Like
many RRs, purified CpxR can accept a phosphoryl group from AcP (101, 111). AcP,
the high-energy intermediate of the phosphotransacetylase (Pta)-acetate kinase
(AckA) pathway (Fig. 3), has a larger ΔG° of hydrolysis (-43.3 kJ/mol) than ATP (30.5 kJ/mol in complex with Mg2+). This large amount of energy stored by AcP is
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crucial for its role as a global signaling molecule, as this energy is capable of
inducing the conformational changes required for activation of RRs (60, 129). The
phospho-Asp phosphatase activity of CpxA, therefore, could function to prevent
inappropriate AcP-dependent activation of CpxR. In this dissertation I will address
these issues by testing if CpxA possess phosphatase like-activity in vivo, and whether AcP function as a phosphoryl donor to CpxR in vivo.

PTA-ACKA PATHWAY AND ACETYLPHOSPHATE
Reversible in vivo, the Pta-AckA pathway interconverts coenzyme A (CoA),
ATP, and acetate with acetyl-CoA (AcCoA), ADP, and inorganic phosphate (Pi). This
reversibility permits both AcCoA synthesis (acetate activation) and acetate evolution (acetogenesis) (Fig. 3). During acetogenesis, Pta synthesizes AcP and CoA from
AcCoA and Pi, while AckA generates ATP from AcP and ADP.
Simultaneously, AckA produces acetate, which cells freely excrete into the
environment. Thus, the steady-state concentration of AcP depends on the rate of its
formation catalyzed by Pta and the rate of its degradation catalyzed by AckA [reviewed in (145)]. Acetogenesis has several key functions. It recycles CoA, facilitating
glycolytic flux and hence rapid growth in the presence of an excess of a preferred
carbon source (e.g., glucose or pyruvate) [reviewed in (145)]. This function also can
reinitiate stalled tricarboxylic acid (TCA) cycle function, providing CoA to convert αketoglutarate to succinyl-CoA (35). Critically, acetogenesis provides the majority of
ATP in the absence of robust TCA cycle activity (145).
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However, the conversion of AcCoA to acetate and ATP often does not go to
completion; E. coli cells can and do maintain a significant pool of AcP (72, 90, 104).
This pool serves the cell in two distinct and equally important ways. First, AcP
serves as a storage molecule for carbon (C), phosphate (OPO3), and energy in the
form of its high-energy COOPO3 bond (92). Second, AcP can serve as a signaling
molecule [reviewed in (146)].
In the early 1990s, AcP was proposed to act as a global signal by donating its
phosphoryl group to a subset of RRs (91, 141). Intracellular AcP concentration varies in response to the environment. AcP concentrations can be as high as 4 to 5 mM
in wild-type (WT) cells and 15 to 20 mM in ackA mutants (72). These concentrations
are sufficient to induce in vitro phosphorylation of some RRs (84).
Much evidence now exists to support the hypothesis that AcP-dependent
phosphorylation of a subset of RRs contributes to their function in vivo [reviewed in
(146)]. For example, the RR RcsB can be induced to activate capsule biosynthesis
and repress flagellar biogenesis in an AcP-dependent manner (38). Genetic evidence
in support of this proposition was obtained using epistasis analysis. By combining
mutations in the Pta-AckA pathway with mutations in the Rcs 2CST pathway and
then comparing the phenotypes of the resultant double mutants to those of the parental single mutants, Fredericks et al. were able to conclude that AcP acts via RcsB
to activate genes for encapsulation and to repress genes for flagellation (38). This
well-characterized DNA-binding RR controls about 5% of the E. coli genome [reviewed in (87, 103)] and as much as 20% of the S. enterica genome (140), including
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many genes involved in virulence. Thus, AcP influences expression of multiple genes
through a known global regulator.
While many behaviors associated with disruption of the Pta-AckA pathway
correlate with AcP concentrations, some do not [reviewed in (146)]. If a behavior
strictly depends on AcP to donate its phosphoryl group to a response regulator, then
an ackA mutant, which accumulates AcP (72), should elicit a behavior opposite to
that exhibited by a pta mutant, which cannot synthesize AcP (72). However, that is
not always the case. This lack of correlation could be due to a lack of involvement of
AcP, or perhaps because disruption of the Pta-AckA pathway can have more pleiotropic effects on central metabolism. For example, disruption of the Pta-AckA
pathway is likely to affect the flux of acetyl groups through central metabolism [reviewed in (144)].

ACETYL-COENZYME A
AcCoA plays a very important role in cellular metabolism (Fig. 4) . It contributes to fatty acid biosynthesis and serves as the carbon donor to the TCA cycle by
donating its acyl group to oxaloacetate. This transfer of acetyl groups recycles CoA
[reviewed in (144)], the major acyl group carrier in living systems (78). E. coli produces limiting amounts of CoA, and growth arrest initiates once the CoA concentration falls below 5 pmol/108 cells (58). Therefore, cells must recycle CoA to maintain
proper glycolytic flux and therefore growth.
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Similar to AcP, AcCoA concentration has been shown to fluctuate and rapidly
increase when E. coli cells are exposed to some carbon sources like glucose (135).
This increase in AcCoA concentration has the potential to put stress on the limited
CoA pool, potentially leading to metabolic imbalance. When combined with disruption of the Pta-AckA pathway, this imbalance could drastically affect cellular physiology.

ACETYLATION
Protein acetylation is typically thought of as the transfer of an acetyl group
from an acetyl donor, e.g. AcCoA, to a protein. This transfer can occur either at the
amino terminus of a protein (Nα) or to the ε-amino (Nε) group of a lysine residue
(Fig. 5). This transfer is often mediated by an acetyltransferase that can establish
the proper catalytic microenvironment. The acetyltransferase acts as a scaffold, orienting the acetyl group of AcCoA and the amino group of the acceptor protein into
close proximity. The enzyme then promotes deprotonation of the amino group, creating a neutral amino group that serves as a nucleophile that attacks the carbonyl
carbon of AcCoA, acetylating the protein and releasing a free CoA molecule (33).
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Nα-acetylation is considered to be an irreversible modification of either the
deformylated N-terminal methionine or, following cleavage of the N-terminal methionine, the newly exposed amino acid. In eukaryotes, Nα-acetylation of proteins is
extremely common (present on more than 80% of mammalian proteins) and is primarily cotranslational. In bacteria, Nα-acetylation is proposed to be less common,
occurring post-translationally on ribosomal proteins [reviewed in (53)].
In contrast to Nα-acetylation, Nε-acetylation is both dynamic and reversible.
This property permits Nε-acetylation to serve in as regulatory mechanism. The impact of Nε-acetylation varies according to the context. Nε-acetylation can change the
size, charge and/or conformation of the protein. These changes can alter DNA binding affinity, protein stability, protein–protein interactions, protein localization and
protein function. Nε-acetylation is also known to influence other post-translational
modifications [reviewed in (46, 152)], a process known as PTM crosstalk. In general,
evidence of PTM crosstalk is more prevalent in eukaryotic organisms. For example,
gene expression can be regulated at the level of chromatin structure. Numerous residues within the histone tails and several residues within the histone globular domains can be modified in a variety of ways, including acetylation, phosphorylation,
ubiquitination, and methylation[reviewed in (76)]. The combination of these modifications, depending to the context, can act to facilitate or repress transcription. In
some cases the modification of one residue can alter the ability of a second residue
to be implemented by its modifying enzyme(s). For example, phosphorylation of
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serine 10 on histone H3 stimulates the ability of Gcn5 to acetylate histone H3 at lysine 14 (H3K14) (19, 86). A second example of PTM crosstalk in eukaryotes can be
seen with CTD of eukaryotic RNA polymerase II which has been shown to be both
phosphorylated and glycosylated. The pattern or glyscosylation and/or phosphorylation affect the ability of some proteins to interact with RNAP II. Although both glycosylation and phosphorylation can occur on RNAP II CTD, phosphorylation seems
to prevent glycosylation [reviewed in (34)]. The evidence is less extensive that PTM
cross-talk occurs in bacteria; however, multiple proteins have been shown to be
modified by more than one PTM [reviewed in (121)]. For example, the RRs RcsB and
CheY have been shown to be both phosphorylated and acetylated and evidence exists to support the hypothesis that the function of these proteins is affected by both
PTMs (82, 132). While it remains to be determined whether either PTM can affect
the other, some evidence exists that in vitro phosphorylation of RcsB might be affected by its acetylation (Hu, L. I. and Wolfe, A. J. unpublished)
Acetylation of non-lysine residues also has been shown to occur. In bacteria,
Ser/Thr acetylation is known to have a role in virulence. For example, Yersinia pestis
blocks host defense pathways in the inflammatory response by acetylating serine
and threonine residues that are essential in MAPK/NF-κB signaling pathways (94).
Salmonella enterica utilizes a similar mechanism during host invasion (63).
Unless otherwise mentioned, for the remainder of this section, I will focus of
the reversible Nε-Acetylation.
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While in eukaryotic cells, protein acetylation has been extensively studied, in
bacteria and archaea this has not been the case. Until recently, our knowledge of
protein acetylation in bacterial cells was limited to the acetylation of acetyl-CoA synthetase (an enzyme that converts acetate to AcCoA) and CheY (a signal protein central to chemotaxis) [reviewed in (53, 131)]. However, recent global proteomics studies have provided evidence that protein acetylation is widely prevalent in E. coli
(155, 157), S. enterica (139) and more recently B. subtilis (68). These studies indicate that Nε-lysine acetylation might be as prevalent in bacteria as in eukaryotes.
In parallel with what has been reported for eukaryotic cells, protein acetylation in bacteria is thought to be regulated and reversible [reviewed in (53, 130)].
Protein acetylation is thought to be mediated by proteins with lysine acetyltransferase activity (KAT), while deacetylation is thought to be mediated by proteins with
lysine deacetylases (KDACs)
Up to five groups of proteins with KAT activity have been identified: (i) the
Gcn5-related acetyltransferase (GNAT) family, (ii) the MYST family, (iii) the
CBP/p300 co-activators, (iv) the SRC family of co-activators and (v) the TAFII group
of transcription factors [reviewed in (88, 126)].
Of the five groups of proteins with acetyltransferase activity, the GNATs are
the most widely distributed, with over 10,000 members identified across all three
domains of life [reviewed in (136)]. Importantly for bacteriologists, GNATs are
ubiquitous within the bacterial domain and are capable of carrying out a diverse
range of functions. Some GNATs, such as protein acetyltransferase (Pat) from S. en-
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terica, catalyse Nε-acetylation (124), while other GNATs are reported to perform
Nα-acetylation; for example RimI, RimL and RimJ of E. coli (128, 154).
Not all GNATs catalyse protein acetylation. Indeed, the first characterized
members of the GNAT family, the aminoglycoside N-acetyltransferases, were discovered as bacterial enzymes that could acetylate and thus inactivate antibiotics
[reviewed in (27, 118)].
In addition to this acetyltransferase mediated acetylation of proteins, autoacetylation, an intramolecular covalent modification, has also been reported for several eukaryotic KATs [Tip60 (138) and p300 (133) for example] and for the E. coli
proteins acetyl-CoA synthetase (ACS) and CheY (4). Unpublished evidence from the
Wolfe laboratory adds the RR RcsB and the central metabolism protein LpdA to the
list of proteins that appear to autoacetylated (Linda I. Hu, Bui Khanh Chi, Misty L.
Kuhn, Ekaterina V. Filippova, Arti J. Walker-Peddakotla, Katrin Bäsell, Dörte Becher,
Wayne F. Anderson, Haike Antelmann, and Alan J. Wolfe unpublished data).
Two major families of KDACs have been identified. These two families have
been grouped into four classes (49): the zinc-dependent Rpd3/Hda1 family (classes
I, II and IV) (153) and the NAD+-dependent sirtuin family (class III) (8). For each
KDAC class, putative bacterial homologues have been identified [reviewed in (52)],
but only a few have been shown to serve as protein deacetylases and very few of
their protein substrates have been identified (44, 45, 52, 79, 123, 139).
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RNA POLYMERASE AND TRANSCRIPTION INITIATION
The E. coli genome encodes approximately 4500 open reading frames (ORF).
However, the number of RNAP subunits available for transcription is less than half
of that, about 2000 units per cell [reviewed in (55)]. Thus, a large effort is invested
in the decision as to which promoter(s) will be engaged by RNAP, and thus which
genes will be transcribed. Because RNAP is a limited resource, transcription initiation is the major regulatory mechanism used to regulate genomic expression in bacteria.
RNAP is a large multi-subunit complex. Its core (E) is composed of 5 highly
conserved subunits, α2ββ’ω, with homologues found in all domains of life. Although
this core enzymatic complex is capable of synthesizing RNA polymers, its ability to
bind DNA requires interaction with one of the seven σ factors encoded by the E. coli
genome. The complex formed by E and one of the σ factors is called RNAP holoenzyme (Eσ). In E. coli, σ70, encoded by rpoD, is the most abundant σ factor and it is required for transcription of most ORFs [reviewed in (50, 56)].
Although σ70 is the most abundant σ factor in E. coli, the cellular concentrations of the σ factors are very dynamic. It varies with different growth phases and
environmental conditions (55, 57). This change in steady state levels of σ factors
will, consequently, change the probability that E will interact with a particular type
of σ factor. Since different promoters, or groups of promoters, possess binding elements that favor the binding of different σ factors, the concentration of the sigma

23
factors will dictate the genes that can be transcribed at any given time [reviewed in
(50, 56, 114)].
After interaction with one of the σ factors, the Eσ complex is now capable of
interacting with a promoter region. The complex DNA-Eσ is termed RNAP closed
complex (RPc). After the initial promoter interaction, the next step in transcription
initiation leads to melting of the double stranded DNA and the formation of a transcription bubble that begins at a nucleotide hexamer known as the -10 element, because it is located approximately 10 nucleotides upstream of the transcription start
site, which is also included in the transcription bubble. This complex is known as the
open complex (RPo). With the exception of Eσ54, the energy required to drive the
melting of the double stranded DNA comes from large conformational changes in Eσ
and DNA and not from ATP hydrolysis or the hydrolysis of any other energy filled
metabolite. Once the open complex is formed, NTP incorporation drives the transcription reaction forward. This step is known at the transcription initiation complex (TIC). However, at most promoters, RNAP synthesizes short, abortive products
before transitioning to the elongation complex (TEC). During this time, the leading
edge of σ and the active site of the enzyme move forward, but the contacts between
the trailing edge of RNAP and the nucleotide hexamer located approximately 35 nucleotides upstream of the transcription initiation site(–35 hexamer) remain intact.
Transcription elongation occurs once Eσ breaks its contact with the promoter region and progresses downstream. Eventually, the interaction between E and the σ
factor also breaks and σ releases to interact with another E (50). Although a large

24
amount of molecular information is known about the Eσ70 closed and open complexes, not much is known about the intermediate stages [reviewed in (50, 56, 114,
147)].
Availability and interaction with the different σ factors is only one of the
many factors determining transcription initiation. Further selectivity is achieved by
interaction of Eσ with one of the approximately 300 transcription factors in E. coli.
While most of these transcription factors contain DNA-binding elements, approximately 10% of them interact directly with RNAP, regulating transcription elongation
and termination (57). Similarly to σ factors, the concentration of these transcription
factors is affected by growth phases and environmental conditions, as well as nutritional status. In general, the vast majority of these transcription factors are present
in very small concentrations, usually less than 100 molecules per cell. Most transcription factors possess very weak affinity for RNAP, which in some cases can be
altered via a covalent posttranslational modification or a non-covalent interaction
with a ligand. It is important to mention that although some of these modifications
can increase the affinity between transcription factors and RNAP, the overall affinity
between them must remain relatively weak to allow for a quick turnover of transcription factor that interacts with RNAP. This relatively weak interaction is also required to facilitate promoter clearance, as a complex that is too stable will have difficulty breaking free from the many interactions formed at the promoter level, and
will be less likely to progress into transcription elongation [reviewed in (50, 56)].
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In addition to binding elements for σ factors, and in some cases binding sites
for some transcription factors, some promoters may also contain a stretch of adenosines (A) and thymidines (T) upstream of the σ factor interaction site. This AT-rich
stretch, termed the UP-element, can serve as an additional stability point as the carboxy-terminal domain of the α subunit of RNAP (αCTD) can make direct contact to
this region (48, 113).
The α subunit is composed of two independently folded domains tethered by
a flexible linker region of approximately 15 amino acids (9). Dimerization of the
amino-terminal domain (αNTD) is the nucleating step for E assembly (156), while
the CTD directly interacts with DNA, in and across a minor groove, via a helixhairpin-helix motif (7, 48, 112).
The UP-element is widely distributed in bacteria, plasmids and phages. Genetic and biochemical analysis of the interaction between αCTD and the UP-element
in the rrnB promoter has identified a crucial patch of amino acids (Arg-265, Asn294, Gly-296, Lys-298 and Ser-299) on the αCTD, known as the 265 determinant,
that is required for DNA interaction (7, 112). This information has been confirmed,
at the atomic level, by X-ray structure analysis of the interaction between αCTD and
the UP-element on the lac promoter (7). In addition to directly interacting with DNA,
the 265 determinant has been shown to be directly involved in a protein-protein interaction between αCTD and the transcription elongation protein NusA (116).

CHAPTER TWO
MATERIALS AND METHODS
BACTERIAL STRAINS, BACTERIOPHAGE AND PLASMIDS
All bacterial strains used in this study are listed in Table 1. Derivatives were
constructed by generalized transduction with P1kc (for details, see Generalized P1
transduction). The transcriptional fusion ϕ(PcpxP’-lacZ) carried by λPcpxP was a
generous gift from Thomas Silhavy (Princeton University, Princeton, NJ). All plasmids used in this study are listed on Table 1. Derivatives were constructed either via
cloning or by site-directed mutagenesis (for details, see Plasmid Construction and
Site-Directed Mutagenesis).

CULTURE CONDITIONS
For strain construction, cells were grown in Luria Broth (LB) containing 1%
(wt/vol) tryptone, 0.5% (wt/vol) yeast extract, and 0.5% (wt/vol) potassium chloride; LB plates also contained 1.5% agar. For promoter activity assays, cells were
grown in tryptone broth containing 1% (wt/vol) tryptone and 0.5% (wt/vol) potassium chloride. Potassium chloride was used instead of sodium chloride because sodium has a negative effect on the survivability of WT cells at alkaline pH (64). For
some experiments, the medium (liquid or solid) was buffered with base and acid to
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a final concentration of 100 mM at ratios required to achieve the desired pH. No KCl
was added to TB when a potassium-based buffer was used to adjust the pH. Cell
growth was monitored spectrophotometrically (DU640; Beckman Instruments,
Fullerton, CA) by determining the optical density at 600 nm (OD600).
Antibiotics were prepared as a stock solution 1000 times the working concentration. Working concentrations were as follows: ampicillin, 100 μg/mL; kanamycin, 40 μg/mL; spectinomycin 100 μg/mL; tetracycline, 15 μg/mL and chloramphenicol, 25 μg/mL. Stock solutions of ampicillin, kanamycin and spectinomycin
were dissolved in water and filter sterilized. Stock solutions of tetracycline and
chloramphenicol were dissolved in 50% and 100% ethanol, respectively, and filter
sterilized. All antibiotic stocks were stored at -20°C. When necessary, isopropyl β-D1-thiogalatopyranoside (IPTG) was added to the media at the indicated concentration to induce gene expression from a plasmid vector. Nile red (Sigma Aldrich), at a
final concentration of 25 µg/ml, was added to LB plates to detect in vivo PHB accumulation. PHB detection using Nile red will be explained later.

GENERALIZED P1 TRANSDUCTION
A single colony was inoculated in TB and grown overnight at 37°C aerobically
with agitation at 250 RPMs. In the morning, 50 μL of overnight culture were added
to 5 mL of TB for transduction (TBT) (0.2% [wt/vol] glucose from a 20% [wt/vol]
stock solution, 10 mM CaCl2, 10 mM MgSO4, and 0.4 mM FeCl3 in TB). The overnight
culture was grown in TBT until it reached an OD600 of approximately 0.5. One mL of
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cells was infected with 10-100 μL of phage lysate and incubated statically at 37°C for
30 minutes. After incubation, 200 μL of 1M sodium citrate (pH 5.5) were added to
prevent a second round of phage absorption. The cells were pelleted using a tabletop centrifuge at 16000 RCF for 1 minute at room temperature. The supernatant
was decanted and the pellet resuspended with 500 μL LB and 200 μL 1M sodium
citrate. The cells were then incubated aerobically at 37°C with agitation at 250 RMP
for 70 minutes to give them time to develop antibiotic resistance. After the second
round of incubation, the cells were pelleted as described before. The supernatant
was decanted and the pellet was resuspended with 50 μL 1 M sodium citrate. The
entire cell suspension was plated onto LB agar plates with appropriate antibiotics
required for the desired selection.

PLASMID CONSTRUCTION
Plasmids pPHB1 and pPHB3. These plasmids were constructed by Shaun R. Brinsmade (UW-Madison). Alleles phbCAB+ were amplified from Ralstonia solanacearum
strain GMI1000 (a kind gift from Caitilyn Alen, UW-Madison) using forward primer
5’—ATC GAA CCC GGG ATG GCA TCG CGT CAC AA—3’ and reverse primer 5’—AGC
ATG AGT GCC CCG GGT CAG CCC ATG T—3’. Bases underlined indicate the SmaI restriction site engineered into each primer. The resulting ~4-kb fragment was Atailed and gel-purified using the QIAquick gel extraction kit (Qiagen). This product
was ligated into the multiple cloning site of plasmid pGEM-T-Easy (Promega). The
resulting plasmid was ~7-kb. From this plasmid, named pPHB1, the Rs phbCAB+
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genes were cut out using SmaI. The resulting ~4-kb fragment was gel-extracted and
ligated into plasmid pTAC-85 (89) that had been cut with NcoI and the resulting single-stranded DNA overhangs blunted with mung bean nuclease and dephosphorylated using shrimp alkaline phosphatase. The resulting plasmid was ~9.1-kb and
was named pPHB3.

Plasmid pBPL001. The WT cpxR allele was amplified from pCA24n-CpxR using primers cpxRFNdeI (5’-GGTATTTAACATATGAATAAATCCTG-3’) and cpxRRHindIII (5’GGTATTTAACATATGAATAAAATCCTG-3’). The resulting amplicon was ligated into
pJET1.2, using the CloneJETTM PCR Cloning Kit (Fermentas). The ligated product was
cut out of pJET1.2 with NdeI and HindIII, gel-extracted, ligated into pET28 downstream of the IPTG-inducible promoter, and fused to a C-terminal His6 tag. The resulting plasmid was named pBPL001.

Plasmid p770-cpxP. This plasmid is a derivative of p770 (a generous gift from Rick
Gourse at the University of Wisconsin-Madison). It is an ampicillin-resistant ColE1based plasmid that has the tandem rrnB operon terminators T1 and T2 located
downstream of the insertion sites for the promoter. The cpxP promoter region was
amplified from strain BW25113 with the following primer pair: cpxP’FEcoRI (5’AATAGGGAATTCAGTTCTCGGTCATC-3’) to insert the EcoRI site upstream of the
promoter region and cpxP’RHinDIII (5’-GCAGCGAAGCTTAATGAACTGACTG-3’) to
insert the HinDIII site downstream. The resulting amplicon was ligated into pJET1.2,
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using the CloneJETTM PCR Cloning Kit (Fermentas) following kit instructions. The
ligated cpxP insert was sequenced, digested out of pJET1.2 with EcoRI and HindIII,
and gel-extracted. The gel-extracted fragment was cloned into previously digested
p770 via overnight ligation at room temperature. Ligated plasmids were transformed into E. coli DH5α cells. Plasmids were recovered from transformants and restriction digested to screen for the presence of the cpxP promoter. The presence of
the promoter was confirmed via sequencing analysis. The plasmid containing the
correct insert was purified, stored at -20°C and named p770-cpxP.

SITE DIRECTED MUTAGENESIS
Site directed mutagenesis of plasmids pBPL001, pIA900 and pREII was conducted using Agilent Technologies’s QuickChange Site-Directed Mutagenesis Kits,
according to manufacturer’s instructions. The mutations were confirmed by sequence analysis of the purified mutagenized plasmids.

TRANSFORMATION
Two distinct transformation methods were used: TSS and electroporation.
TSS – 1 ml of overnight cell culture was pelleted at room temperature for 1 minute
at 16000 RCF using a table-top centrifuge. The pellet was resuspended with 100 µl
TSS [10% (wt/vol) poly(ethylene glycol), 5% (vol/vol) DMSO and 50 mM MgSO4 or
MgCl2 in LB]. After resuspension, 50 ng of plasmid DNA was added to the resuspended cells, the mixture was incubated on ice for 30 minutes. After ice incubation,

31
0.9 mL of LB was added, and the cells were incubated for 1 hour at 37°C with aeration. After 37°C incubation, the cells were pelleted one more time as described
above, the supernatant was decanted, and the cells were resuspended in 250 μL LB.
25-100 µl of the resuspended cells were used for plating on an LB agar plate containing the appropriate antibiotic for selection.

Electroporation - For electroporation, the recipient cells were made competent by
inoculating 30 mL of LB in a 250 mL baffled flask with 500 µL of overnight culture.
The culture was incubated with aeration rotating at 250 RPM at 37°C until OD600
reached 0.4-0.6. The culture was split into two Oakridge tubes and spun down at
10000 RCF for 10 minutes at 4°C. After pelleting the cells, the supernatant was aspirated, and the cell pellet was resuspended with 1 mL of ice-cold sterile water. After
resuspension, an additional 9 mL of ice cold water was added to the tube, bringing
the total volume to 10 mL and the cells were spun one more time at 10000 RCF for
10 minutes at 4°C. At the end of the second spin, the supernatant was gently decanted immediately, as the pellet is not very compact and stable at this point. The pellet
then was resuspended one more time with 1 mL of ice cold water, transferred to a
1.5 mL eppendorf tube, and spun down at 16000 RCF for 1 minute, using a table top
centrifuge at room temperature. The supernatant then was aspirated one more time,
the pellet was resuspended with 200 µl of water, divided into 50 µl aliquots and
stored at -80°C for future use.
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Transformation began by mixing 50 ng of purified plasmid DNA with 50 µL of
electro-competent cells. The DNA-cell mixture was then transferred to a 1 mm
chilled electroporation cuvette and electroporated at 1.8 KV. After electroporation,
the cells were immediately rescued by the addition of 1 mL of LB, transferred to a
small test tube, and incubated at 37°C, rotating at 250 RPM for 1 hour. After incubation, 20-100 µL of cells were plated onto LB agar plates containing the appropriate
concentration of antibiotic required for selection of transformants. Outgrowth was
often, but not always, carried out overnight at 37°C.

PROMOTER ACTIVITY ASSAY
To monitor promoter activity from ϕ(PcpxP’-lacZ), cells were grown aerobically with agitation at 250 rpm at 37°C in TB that was unbuffered or TB that was
buffered either at pH 7.0 (TB7) or at pH 8.0 (TB8). At regular intervals, 50 µL aliquots were harvested and added to 50 µL of All-in-One β-galactosidase reagent
(Pierce Biochemical). β -galactosidase activity was determined quantitatively with
the Y-PER β-galactosidase assay kit (Pierce Biochemical), using a microtiter format.
Promoter activity was plotted versus OD600. For some experiments, only the peak
activity is shown. Each experiment included three independent measurements and
was repeated at least once.

33
pH SENSITIVITY ASSAY
Cells were grown aerobically with agitation at 250 rpm at 37°C in LB buffered at pH 7.0 (LB7) until either mid-exponential phase or early stationary phase,
harvested, serially diluted in LB7, and plated onto LB plates buffered at the specified
pH. The plates were incubated overnight at 37°C, the colonies were counted, and the
colony diameters were measured.

NILE RED
Nile Red was used to detect the production and accumulation of polyhydroxybutyrate (PHB) on LB agar plates by E. coli cells carrying plasmid pPHB3. A
single colony was streaked onto LB agar plate containing Nile Red at a final concentration of 0.5 µM/ml, 50 µM IPTG to induce PHB expression and 25 µg/ml ampicillin
to force the cells to maintain the plasmid. The plates were incubated overnight at
37°C. After incubation, PHB accumulation was detected by exposing the plates to
ultraviolet light (λ=312 nm).

TRANSMISSION ELECTRON MICROGRAPH
Transmission electron micrography was used to detect the production and accumulation of polyhydroxybutyrate (PHB) granules in the cytoplasm of E. coli cells. A single colony of strain PAD 282 carrying plasmid pPHB3 was incubated overnight in 5
mL of TB7 containing 100 μg/mL ampicillin. 2 mL of the overnight culture was collected and the cells were pelleted using a table-top centrifuge at 16000 RCF for 1
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minute at room temperature. The cell pellet was resuspended with 1 mL of fixing
solution (1.2% glutaraldehyde, 0.45 M cacodylate buffer pH 7.3 and 0.1% ruthenium
red) and incubated overnight at room temperature. After overnight incubation, the
cells were pelleted at room temperature using a table-top centrifuge at 16000 RCF
for 3 minutes, the eppendorf tube was rotated 180° and spun again for 1 min at the
same RCF. After the final centrifugation, the supernatant was decanted and the cell
pellet was washed for 10 minutes twice with washing buffer (0.45 M cacodylate
buffer pH 7.3 and 0.1% ruthenium red). After the second wash, the cell pellet was
incubated for 1 hour at room temperature in washing buffer containing 4% osmium
tetroxide, after which they were washed twice again for 10 minutes with washing
buffer. The cells were then dehydrated by a series of 15-minute ethanol washes at
room temperature with increasing concentration of ethanol: 25%, 50%, 75%, 90%
and four 15-minute washes with 100% ethanol, followed by two 10-min washes
with propylene oxide at room temperature. At the end of the second propylene oxide wash, the pellet was incubated overnight with a 1:1 mixture of resin and propylene oxide, followed by a 7-8 hour incubation with a 3:1 mixture of resin and propylene oxide, ending with an overnight incubation in 100% resin. After the last resin
incubation, the samples were placed in molds, filled with fresh resin and placed in
the oven overnight, after which the samples were ready to be processed and visualized.
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WESTERN IMMUNOBLOT ANALYSIS
For Western Immunoblot analysis, 1.5 ml of cell culture was used. The cells
were pelleted by centrifugation. Cell lysis was accomplished by one of the following
methods: sonication, resuspension in 2x SDS buffer (120 mM Tris-Cl [pH 6.8], 4%
SDS, 0.2% bromophenol blue, 20% glycerol and 10% 2-mercaptoethanol), or BugbusterTM (according to manufacturer’s instructions). The protein samples were resolved by electrophoresis on a SDS-PAGE 12% polyacrylamide gel, transferred to
PVDF or nitrocellulose membrane, and subjected to Western immunoblot analysis.
Protein detection occurred by incubating the membrane with primary antibody in 5% milk solution overnight at 4°C with shaking. Secondary goat anti-rabbit
(Cell Signaling Technology®) immunoglobulin G antibody at a 1:1000 dilution, or
goat anti-mouse (Millipore) immunoglobulin G antibody at 1:5000 dilution both
conjugated to horseradish peroxidase were used for 1 hour at room temperature
with shaking. For visualization, enhanced chemiluminescence Western immunoblotting reagents (Cell Signaling Technology®) were used, according to the manufacturer’s instructions.
When necessary, membrane stripping was performed with OneMinute®
Western Blot Stripping Buffer (GM Biosciences), according to the manufacturer’s
instructions.
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IMMUNOPRECIPITATION
For immunoprecipitation, 50 mL buffered TB cultures were collected after
7.5 hours of incubation at 37°C, pelleted by centrifugation, resuspended in 5 mL TE
buffer and lysed by sonication. 1 mL of lysate was used for immunoprecipitation of
RNAP with RNAP β mouse monoclonal antibodies (NeoClone Biotechnology) or immunoprecipitation of CpxR with MBP-CpxR rabbit polyclonal antibody (111) and
rotated overnight at 4°C. Protein G-Sepharose® (Sigma) was used to ‘pull down’ antibodies from cell lysate. The precipitated beads were washed three times with TE
buffer and once with wash buffer containing 100 mM NaCl and 50 mM Tris-HCl at
pH 7.2. Loading buffer was added directly to the beads and samples were heated to
95°C for 5 minutes. Samples were separated by SDS-PAGE and stained with NOVEX®
Colloidal Blue Stain (Invitrogen), according to the manufacturer’s instructions.

ORBITRAP-MASS SPECTROMETRY AND PROTEIN IDENTIFICATION
The α, β and β’ bands were excised and subjected to tryptic digestion, as described previously (20). Tryptic peptides were separated and measured online by
ESI-mass spectrometry using a nanoACQUITY UPLC™ system (Waters, Milford, MA)
coupled to an LTQ Orbitrap™ XL mass spectrometer (Thermo Fisher Scientific, Waltham, MA). A trap column (Symmetry® C18, 5 µm, 180µm inner diameter x 20mm,
Waters) was used for desalting. Elution was performed onto an analytical column
(BEH130 C18, 1,7 µm, 100 µm inner diameter x 100mm, Waters) by a binary gradi-
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ent of buffers A (0.1% (v/v) acetic acid) and B (99.9 % (v/v) acetonitrile, 0.1% (v/v)
acetic acid) over a period of 80 min with a flow rate of 400 nl/ min. The Orbitrap XL
was operated in data-dependent MS/MS mode using the lockmass option for real
time recalibration.
Proteins were identified by searching all MS/MS spectra in “dta” format
against an E. coli database (extracted from the Uniprot-KB database:
http://www.uniprot.org/uniprot/?query=Escherichia+coli+K12&sort=score) using
Sorcerer™-SEQUEST® (Sequest v. 2.7 rev. 11, Thermo Electron including Scaffold_3_00_05, Proteome Software Inc., Portland, OR). The Sequest search was carried out considering the following parameters: a parent ion mass tolerance - 10
ppm, fragment ion mass tolerances of 1.00 Da. Up to two tryptic miscleavages were
allowed. Methionine oxidation (+15.99492 Da), cysteine carbamidomethylation
(+57.021465 Da) and lysine acetylation (+42.010571 Da) were set as variable modifications. Proteins were identified by at least two peptides applying a stringent SEQUEST filter. Sequest identifications required at least ΔCn scores of greater than
0.10 and XCorr scores of greater than 1.9, 2.2, 3.3 and 3.8 for singly, doubly, triply
and quadruply charged peptides. Acetylated peptides that passed these filter criteria
were examined manually and accepted only when b- or y- ions confirmed the acetylation site.
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CpxR EXPRESSION AND PURIFICATION
CpxR expression was carried out in BL21 (DE3) cells transformed with
pBPL001. An overnight culture of the transformants was used to inoculate 1 L of LB
at an initial OD600 of 0.05. The culture was incubated at 37°C with shaking at 250
RPM. Once the OD600 reached 0.6, 250 μM IPTG was added to the culture to induce
CpxR expression. After three hours of induction, the cell pellet was collected by centrifugation at 10000 RCF for 10 minutes at 4°C and stored at -20°C overnight.
Cell lysis began by resuspending the pellet with 10 mL BugBuster (Novagen®) and
10 μL lysonaseTM (Novagen®). The resuspended cell pellet was incubated for 30
minutes at room temperature with gentile shaking. Following this room temperature incubation, 30 mL of pH 8.0 resuspension buffer (50 mM Na2HPO4, 1.4 M NaCl,
20 mM imidazole, 0.1% Tween 20, 5% ethanol and 15 mM -mercaptoethanol) was
added to the resuspended pellet. The cell debris was pelleted by centrifugation at
15000 RCF, at 4°C for 30 minutes. The supernatant was loaded onto a 500 μL TALON® Metal Affinity Resin (Clontech) column, washed with 10 mL wash buffer (50
mM Na2HPO4, 0.3 M NaCl, 30 mM imidazole, 0.1% Tween 20 and 0.5% ethanol)
buffered at pH 8.0. CpxR elution was performed in a stepwise manner by flowing
500 μL of wash buffer with increasing imidazole concentration from 35 mM to 85
mM in 5 mM increments. Fractions 6-11 were collected, combined and dialysed
overnight at 4°C into storage buffer (10 mM Tris-HCl pH 8.0, 100 mM KCl, 50% glycerol, 10 mM MgCl2, 0.1 mM EDTA and 1 mM DTT). The dialysed protein was divided
into aliquots, which were stored at -80°C for future use.
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IN VITRO PHOSPHORYLATION
In vitro phosphorylation of CpxR was carried out by incubating lithium potassium AcP (Sigma Aldrich) with purified His-tagged CpxR at 30°C for 15 minutes
in buffer containing 40 mM Tris-HCl pH 8.0, 10 mM MgCl2, 40 mM KCl and 1 mM
DTT. The reaction was quenched by the addition of SDS loading buffer.

DETECTION OF PHOSPHORYLATED CpxR
Whether from cell lysates or from in vitro phosphorylation, phosphorylated
CpxR was detected by first separating phosphorylated from nonphosphorylated
CpxR using Zinc (II) Phos-TagTM SDS- PAGE [10% acrylamide (29:1), 350 mM Tris
pH 6.8, 0.1% SDS, 75 µM Phos-TagTM (NARD Institute LTD) and 150 µM Zn(NO3)2]
(Boulanger-Castaing, A., and Hinton, D. M., personal communication). Purified protein was detected by staining the gel with SimplyBlueTM (Invitrogen), whereas protein from cell lysate was visualised by Western immunoblot with anti-His6 antibody
(CellSignaling). Cell lysis for Phos-TagTM analysis was executed at 4°C with 2X-SDS
loading buffer. Prior to transfer of the protein onto the membrane, the gel was incubated at room temperature with gentle shaking for 15 minutes in Towbin buffer (50
mM tris and 40 mM glycine) containing 1 mM EDTA to chelate the zinc and then for
another 15 minutes in only Towbin buffer.
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IN VITRO ACETYLATION
In vitro acetylation of RNA polymerase was conducted with two distinct acetyl donors: acetyl-CoA (AcCoA) and acetylphosphate (AcP).
AcCoA - In vitro acetylation of purified RNA polymerase with AcCoA and purified
His6-YfiQ was carried out by mixing 1.5 µM YfiQ, 3.5 µM RNAP and 0.05 mM [14C]AcCoA in an in vitro acetylation buffer (50 mM Tris-HCl pH 8.0, 10% glycerol, 10 mM
sodium butyrate, 1 mM DTT) to a final volume of 20 µL. The reaction was incubated
for 1 hour at 37°C and stopped by the addition of NuPAGE 4X SDS loading buffer.
For visualization, the samples were heated at 95°C for 2 minutes, and resolved using a 12% acrylamide SDS-PAGE gel. After sample separation, the gel was
dried for 2 hours using a gel dryer. Images were obtained by exposing a storage
phospho screen to the dry gel overnight. The screen was read using a Typhon phosphoimager.
AcP - In vitro acetylation of purified RNA polymerase with AcP was carried out by
mixing 3.5 µM RNAP with AcP at concentrations ranging from 0-40 mM in in vitro
transcription buffer (40 mM Tris-HCl pH 8.0, 10mM MgCl2, 50 mM KCl, and 1mM
DTT) and incubated for 1 hour at 30°C. After 1 hour, the reaction was stopped by the
addition of standard 2X SDS loading buffer. Protein acetylation by AcP was detected
by Western immunoblot analysis using an antibody against acetylated lysine
(CellSignaling) at a ratio of 1:500.
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IN VITRO TRANSCRIPTION
In vitro transcription of cpxP and all other promoters described in this dissertation was executed by multiple round transcriptions. The final volume of the in
vitro transcription reaction was 25 µL and contained 1x in vitro transcription buffer
(40 mM Tris-HCl pH 8.0, 10mM MgCl2, 50 mM KCl, 1mM DTT and 25 ng BSA), 1X
NTP mixture (200 µM ATP, CTP and GTP, and 10 µM UTP), 2 µCi alpha [32P]UTP, 50
ng p770-cpxP plasmid, purified His6-CpxR at concentrations ranging from 0.0-0.8
µM, AcP at concentrations ranging from 0 – 40 mM, and 10 nM of purified RNA polymerase-containing sigma 70 (Eσ70). When multiple reactions were performed per
experiment, they were started at 30 second intervals by the addition of Eσ70 and incubated at 30°C for 15 minutes. After incubation, the reactions were stopped (also
at 30-second intervals) by the addition of 25 µl of 2x stop solution (7 M Urea, 10 mM
EDTA, 1% SDS, 2X TBE and 0.05% bromophenol blue). Immediately following the
addition of the stop solution, the reactions were transferred onto ice.
The transcript fragments were separated using a denaturing acrylamide gel
containing (6% acrylamide [19:1 acryl.:bis.], 7 M urea and 1x TBE). Polymerization
was initiated by the addition of 0.01% of freshly made 10% APS solution and
0.001% TEMED and allowed to polymerize for 1 hour and 30 minutes undisturbed
at room temperature.
23 µL of the in vitro transcription/stop solution reaction was loaded into the
gel wells. The samples were allowed to run at approximately 200V for approximate-
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ly 1.5-2 hours until the dye reached a position approximately 3 inches from the bottom of the gel, which keeps the unincorporated radioactivity on the gel and makes
cleaning up the radioactive waste much easier. 1x TBE was used as the running
buffer. Prior to phosphor imaging, the gels were dried using a gel drier for 2 hours.
Images were obtained by exposing a storage phosphor screen to the dry gel overnight. The screen was read using a Typhon phosphoimager. The unused in vitro
transcription reaction was stored at -20°C.

RNA POLYMERASE EXPRESSION AND PURIFICATION
RNAP expression - A single colony of BL21 (DE3) cells carrying plasmid
pIA900 was inoculated into 50 mL of LB containing 100 μg/mL ampicillin and incubated overnight at 37°C with aeration, rotating at 250 RPM. This overnight culture
was used the following day to inoculate 1 L of LB containing 100 µg/mL ampicillin
in a 2 L baffled flask, bringing the OD600 to 0.05. The culture was incubated at 37°C
with aeration, rotating at 250 RPM until the culture OD600 reached 0.6, at which
point 1 mM IPTG was added to induce RNA polymerase expression. RNAP expression was allowed to continue for approximately 6 hours under the same conditions
before the culture was split into two 500 mL aliquots and the cells were pelleted by
centrifugation at 10000 RCF for 10 minutes at 4°C. After centrifugation the supernatant was decanted and the cell pellets were placed at -20°C overnight or until cell
lysis.
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Protein extraction - For protein extraction, the cell pellets were allowed to
thaw on ice. After thawing, 5 mL BugBuster (Novagen®) and 5 μL lysonaseTM (Novagen®) was used to resuspend the cell pellets. After resuspension, the mixture
were transferred to OakRidge tubes and incubated at room temperature for 30
minutes with gentle shaking. After incubation, 15 ml of RNAP resuspension buffer
pH 8.0 was added (50 mM Na2HPO4, 1.4 M NaCl, 20 mM imidazole, 0.1% Tween 20,
5% ethanol and 15 mM β-mercaptoethanol). Cell debris was pelleted at 16000 RCF
for 30 min at 4°C, after which the supernatant was collected for protein purification.
RNA Polymerase Purification – Purification of RNAP was conducted by passing the supernatant through a 1 mL cobalt resin bed that had been previously
washed twice with 10 mL of water and equilibrated with 10 mL resuspension buffer. After the cell lysate was passed through the column, the column was washed
with 10 mL wash buffer at pH 8.0 (50 mM Na2HPO4, 0.3 M NaCl, 30 mM imidazole,
0.1% Tween 20 and 5% ethanol). Protein elution was achieved by passing 3 mL of
wash buffer containing 300 mM imidazole through the column. The eluted solution
was collected and diluted into 3 mL TGED (0.01 M Tris-HCl pH 8.0, 5% glycerol, 0.1
mM EDTA, 0.1 M NaCl and 2 mM DTT). The diluted eluate was loaded onto 400 µL of
heparin resin previously washed twice with 10 mL of water and equilibrated with
TGED. The flow-through was collected and passed over the column a second time,
after which the column was washed with 6 ml TGED containing 0.2 M NaCl, and
RNAP was eluted from the column with 3 mL of TGED containing 0.6 M NaCl. The
flow-through was transferred into a dialysis cassette and placed into 1 L dialy-
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sis/storage buffer (10 mM Tris-HCl pH 8.0, 100 mM KCl, 50% glycerol, 10 mM
MgCl2, 0.1 mM EDTA and 1 mM DTT) overnight at 4°C with gentle stirring. After dialysis the samples were divided ino aliquots and stored at -80°C for future use.

CHAPTER THREE
RESULTS
ACETYLPHOSPHATE AS A PHOSPHORYL DONOR
In this chapter, I will address the hypothesis that AcP can function as a phosphoryl donor to RRs in vivo. Using a combination of genetic and biochemical approaches, I will specifically test the hypothesis that the RR CpxR can be phosphorylated by AcP in vivo, and that this phosphorylation event affects transcriptional
regulation of the E. coli stress-responsive gene cpxP.

DOES cpxP TRANSCRIPTION RESPOND TO GENETIC MANIPULATIONS
PREDICTED TO AFFECT INTRACELLULAR LEVELS OF AcP?
Linkage between AcP and several 2CST pathways has been proposed previously [reviewed in (144, 145)]. Only a few studies, however, have provided strong
genetic evidence for this linkage in vivo (38, 119). As part of my efforts to map the
impact of AcP on transcriptional regulation of E. coli promoters, I re-explored the
relationship between AcP and the transcriptional regulation of cpxP, via genetic manipulation of the Pta-AckA pathway and the 2CST pathway CpxAR.
cpxP is the most sensitive of the more than 100 E. coli genes predicted to be
regulated by phosphorylation of CpxR (29, 30). cpxP transcription requires the RR
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CpxR and it is thought to be almost exclusively dependent on it (23), making cpxP
transcription a good readout of CpxR phosphorylation.
Although CpxR is thought to be absolutely required for cpxP transcription,
the cognate SK CpxA is not. cpxP transcription can still be induced in cpxA mutants
when glucose is supplemented to rich medium (23), an observation that has contributed to the hypothesis that, in the absence of CpxA, CpxR could be phosphorylated by AcP (23).
Besides responding to the addition of glucose to rich medium, the CpxAR
pathway has been shown to integrate and respond to multiple environmental cues,
including entry into stationary phase, alkaline pH, attachment to hydrophobic surfaces, the presence of copper in the extracellular environment and the accumulation
of pilus subunits in the periplasm [reviewed in (137)]. Therefore, before I could determine if AcP influenced cpxP transcription, I first characterized cpxP transcription
both in the presence and absence of glucose and determined whether the previously
reported response to glucose could be the summation of multiple signals or if it was
due solely to the presence of AcP.
To assess cpxP transcription, I measured β-galactosidase activity from
ϕ(PcpxP-lacZ) (23), which is carried by the hybrid bacteriophage λRS88 and present as a monolysogen in the λattB site of the chromosome of WT cells (strain
PAD282) and its isogenic mutants ackA (strain AJW2790), ackA pta (strain
AJW2791), cpxA (strain PAD348), and cpxR1 (strain PAD292) (30) (Table 1). The
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cpxR1 allele has a polar effect on the downstream gene cpxA; thus, the resultant
strain lacks both CpxR and CpxA (24).
I grew these strains in TB at 37°C, harvested cells at regular intervals, and
compared their growth characteristics and β-galactosidase activities. Mutants lacking CpxA or CpxR exhibited growth characteristics indistinguishable from those of
their WT parent. In contrast, mutants lacking AckA or both AckA and Pta, as reported previously (148), grew more slowly but to a similar density (Fig. 6A). Because of
the difference in the growth rate, all data obtained subsequently were plotted versus OD600, although for some experiments, only the last time point is shown.
WT cells exhibited two peaks of cpxP activity; the first and smaller peak occurred in mid-exponential phase (OD600, 0.5) and reached about 13,000 Miller
units, while the second and larger peak corresponded with entry into stationary
phase (OD600, 1.0) and reached about 46,000 Miller units (Fig. 6B). Both behaviors
depended upon CpxA and CpxR, as both cpxA and cpxR mutants exhibited low activity throughout growth. Intriguingly, ackA and ackA pta mutants had a hybrid profile;
they exhibited little activity during exponential growth but displayed substantial
activity during entry into stationary phase. The existence of two activity peaks led
me to speculate whether there were two distinct stimuli, one associated with exponential growth and one associated with entry into stationary phase. To be consistent
with previously published data, I focused on the increase in cpxP transcription as
the cultures entered stationary phase.
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STATIONARY-PHASE BEHAVIOR IS A CpxA-DEPENDENT
RESPONSE TO ALKALINE pH.
cpxP transcription has been reported to become activated in response to
both elevated pH (23, 95) and entry into stationary phase (28, 30). Because TB is
composed primarily of amino acids and because consumption of amino acids leads
to the production of ammonia (104, 148), I expected that the culture pH would rise
as the cells consumed amino acids and entered stationary phase and that the increased pH could lead to increased cpxP transcription. To test this hypothesis, I
monitored the pH of the culture medium throughout growth and found that all five
strains (WT, cpxA, cpxR, ackA and ackA pta) behaved almost identically (Fig. 6C).
Each strain dramatically alkalinized its environment during the transition from exponential to stationary phase. In each case, the maximum pH reached by the culture
was about 8.4. During mid-exponential growth, the cpxA and cpxR mutants and their
WT parent slightly acidified their environments before alkalinizing them. The ackA
and ackA pta mutants, in contrast, did not do this. This behavior can be attributed to
the substantially reduced ability of mutants that lack a functional Pta-AckA pathway
to generate and excrete acetate (104, 148).
Since the increase in pH was concomitant with entry into stationary phase, I
performed two different experiments to distinguish between these two potentially
distinct stimuli. First, I grew cells at 37°C in TB buffered at pH7 or TB buffered at
pH8, harvested cells at regular intervals, and monitored their growth and cpxP activity. When grown at pH 8.0, WT cells exhibited about five times more promoter activ-
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ity than they exhibited when they were grown at pH 7.0. In contrast, cpxA mutant
exhibited weak promoter activity regardless of the pH (Fig. 7B). Since both types of
cells grew more than twice as slowly at pH 8.0 as they did at pH 7.0 (Fig. 7A), it is
possible that the higher activity at pH 8.0 could have been due to the lower growth
rate instead of the higher pH. To differentiate between these two possibilities, I
grew WT cells and cpxA mutants at 37°C in either unbuffered TB or TB buffered at
pH7 (TB7). I harvested cells at regular intervals, and monitored their growth and
cpxP activity (Fig. 8). WT cells exhibited high levels of cpxP activity in TB but not in
TB7. In contrast, buffering had no significant effect on the cpxP activity exhibited by
cpxA mutants. These results support the conclusion that pH is the primary stimulus
behind the cpxP activity exhibited by WT cells as they enter stationary phase and, by
extension, the isogenic ackA and ackA pta mutants. Furthermore, these data lend
credence to the reports that the pH response requires CpxA (23, 95).

cpxP RESPONSE TO EXCESS CARBON REQUIRES THE Pta-AckA PATHWAY
It has been reported that exposure to exogenous glucose induces a CpxRdependent cpxP transcription that depends on AcP (23, 24). However, the medium
used to derive this conclusion was not buffered. Since I found that pH has a significant effect on cpxP transcription, I revisited this conclusion.
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Exposure to pyruvate (a three-carbon glycolytic intermediate) results in
greater accumulation of intracellular AcP than exposure to glucose (a six-carbon
compound) (64, 72). Thus, to investigate the effect of AcP on cpxP transcription, I
began by exposing cells to pyruvate. To be able to compare the cpxP responses to
the two compounds, I standardized the concentration to the total number of carbons. Since 0.4% was the glucose concentration used previously (23, 24), I conducted my experiments with 0.8% sodium pyruvate. I grew WT cells and cpxA mutants
at 37°C in pyruvate-supplemented TB7, harvested cells at regular intervals, and
monitored their growth (data not shown) and cpxP activity (Fig. 8). Although WT
cells responded to the presence of pyruvate, the total activity was less than one-half
that of WT cells grown in unbuffered pyruvate-supplemented TB. In contrast, cpxA
mutants responded strongly when they were exposed to pyruvate regardless of
buffering. As reported previously for glucose (23), the cpxA mutant response to pyruvate was stronger than the response of its WT parent. Thus, in this context, CpxA
inhibited the response to pyruvate, a behavior consistent with its reputed phosphoCpxR phosphatase activity (36, 111). Furthermore, my data corroborated previous
observations that seem to support the proposition that CpxR can become activated
in a CpxA-independent manner.
To determine if the CpxA-independent response to pyruvate requires the
Pta-AckA pathway, I performed an epistasis analysis. I combined mutations in the
Pta-AckA pathway with mutations in the CpxAR signaling pathway and compared
the behavior of the cells in the presence and absence of pyruvate (Fig. 9A). WT cells
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responded moderately (about threefold) to pyruvate and only upon entry into stationary phase. In contrast, the cpxA mutant cells responded early and dramatically;
their cpxP activity increased about nine fold from exponential growth to entry into
stationary phase. Thus, the inhibitory effect of CpxA appears to maintain low cpxP
activity throughout exponential growth and to limit the response upon entry into
stationary phase, at least in medium buffered at pH 7.0. Conversely, cells lacking
CpxA and AckA or CpxA, AckA and Pta did not respond to pyruvate (Fig. 9 B and C).
This supports the hypothesis that the response to pyruvate requires the Pta-AckA
pathway.

CPXA-INDEPENDENT cpxP TRANSCRIPTION REQUIRES PTA-ACKA
BUT DOES NOT CORRELATE WITH PREDICTED INTRACELLULAR ACP LEVELS
To activate cpxP activity in the absence of CpxA, CpxR must have an alternative source of phosphoryl groups. Since the pyruvate response requires the PtaAckA pathway, a prime candidate is the pathway intermediate, AcP, which has been
shown to act through at least one other 2CST RR (RcsB) to influence genes involved
in flagellation and encapsulation (38). Furthermore, CpxR can use AcP as a phosphoryl donor in vitro (101, 111), and AcP has been proposed to be responsible for
the CpxA-independent glucose response (6, 23, 24). To be consistent with previously published data, from this point on, I used glucose to induce cpxP transcription and
to test the hypothesis that AcP is responsible for the CpxA-independent, glucoseinduced cpxP transcription.
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If AcP is the phosphoryl donor for CpxA-independent activity, then one
would predict that the cpxA ackA double mutant, which accumulates AcP, would exhibit more activity than the cpxA mutant, while the cpxA ackA pta triple mutant,
which cannot synthesize AcP, would exhibit less. While the latter is true, the former
is not (Fig. 10A). As previously reported, and consistent with the role of CpxA as a
phosphatase, cpxA mutants responded to glucose more strongly than its WT parent.
Although the CpxA-independent response depended on the presence of the PtaAckA pathway, cells that lacked CpxA and AckA exhibited a response that was weaker than that seen by the cpxA mutant and not the predicted stronger response.
Therefore, I concluded that the response to glucose requires an intact Pta-AckA
pathway. The lack of response by the pta ackA mutant argues that the Pta-AckA
pathway is required and the response by the ackA mutant suggests that the response involves AcP, but the weakness of the response suggests that something else
is involved.
To test the hypothesis that AcP does activate cpxP transcription, I took advantage of the fact pta mutants retain a functional AckA and that the Pta-AckA
pathway is reversible. Thus, since AckA converts acetate to AcP, I could set AcP levels by controlling the amount of acetate added to the medium (64), and create a
condition in which we could have AcP at a concentration that is predicted to be
higher than WT, and yet, maintain a functional AckA enzyme.
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To obtain that condition, I grew strains lacking CpxA and either AckA or Pta
or both in TB7 or TB7 supplemented with 15 mM potassium acetate. Both the cpxA
and cpxA pta mutants responded by exhibiting statistically significant cpxP activity
when compare to cells grown in the absence of acetate, while the cpxA ackA and
cpxA ackA pta mutants did not (Fig. 10B). Thus, I concluded that AcP can activate
cpxP transcription. If so, then why is the response weaker when compared to cells
that possess an intact Pta-AckA pathway? One possibility is that an inhibitor exists
under conditions that presumably induce very high AcP concentration. To test this
idea, I exposed cpxA mutants (which possess intact Pta-AckA pathway) to increasing
concentrations of glucose. Consistent with the idea that an inhibitor of cpxP transcription accumulates under conditions that are expected to produce large AcP concentrations, I detected an increase in cpxP when cells were exposed to glucose concentrations up to 0.4%, but a progressive decrease in the presence of larger
amounts, e.g. 4.0% (Fig. 11).
On the basis of these results, I conclude that AcP contributes to cpxP transcription, perhaps via the transfer of a phosphoryl group from AcP to CpxR, as such
a transfer has been shown to occur in vitro (85, 101). Since cpxP transcription fails
to strictly correlate with expected intracellular levels of AcP, it is possible that AcP is
not the sole contributor to CpxA-independent, glucose-induced cpxP transcription.
In this dissertation, I will first ask if a transfer of phosphoryl groups occurs between
AcP and CpxR and later ask whether factors other than CpxR phosphorylation contribute to the CpxA-independent, glucose-induced transcription of cpxP.
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GLUCOSE-INDUCED cpxP TRANSCRIPTION REQUIRES ASP-51,
THE CONSERVED PHOSPHORYL ACCEPTOR RESIDUE OF CPXR
The knowledge that glucose-induced cpxP transcription is affected by AcP,
that it does not require the sensor kinase CpxA, but that it requires the cognate response regulator CpxR (149), led me to re-investigate the role of CpxR phosphorylation. To address this question, I attempted to complement the cpxR1 mutant allele in
a strain that carries the transcriptional fusion Φ(PcpxP’-lacZ) (strain PAD 292; Table 1). Complementation was attempted by transformation with either plasmidborne WT cpxR (pCA24n-cpxR; Table 1) or plasmid-borne cpxRD51A (pCA24ncpxRD51A; Table 1). The latter encodes a mutant protein that lacks the conserved
aspartyl residue that serves as the phospho-acceptor site. Both alleles were expressed from an IPTG-inducible promoter. I grew the resultant transformants in TB
with or without the presence of 0.4% glucose and measured -galactosidase activity
as a reporter of cpxP promoter function. The transformants that expressed WT CpxR
responded to glucose. In contrast, the transformants that expressed CpxRD51A did
not (Fig. 12, left). Since Western immunoblot analysis indicated that the steady
state levels of the WT and mutant forms of CpxR proteins were similar (Fig. 12, inset), the lack of cpxP transcription by cells that express the mutant protein cannot
be explained by a difference in protein expression levels. Instead, this lack of response likely resulted from the mutant protein’s inability to become phosphorylated
(Fig. 13B). I therefore conclude that the response to glucose by cpxP requires AsP51 and propose that this response requires phosphorylation of CpxR.
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THE RESPONSE TO GLUCOSE REQUIRES ACETYL PHOSPHATE
The knowledge that CpxA-independent, glucose-induced cpxP transcription
seems to be, at least in part, dependent on AcP and seems to require phospho-CpxR
led me to investigate if the weak response to glucose by the ackA mutant required
CpxR phosphorylation, perhaps an indicator that AcP could indeed function as a donor of phosphoryl groups to CpxR.
If AcP can function as a phosphoryl donor to CpxR, then the cpxR1 ackA double mutant (strain AJW3827; Table 1), which accumulates AcP (72, 146), should respond to the addition of glucose in a Asp-51-dependent manner. In contrast, I predicted that the cpxR1 pta ackA triple mutant (strain AJW3875; Table 1), which cannot synthesize AcP (72, 146), would not respond to exogenous glucose regardless of
the status of Asp-51. Indeed, the cpxR1 ackA double mutant responded to glucose in
an Asp-51-dependent manner, while the cpxR1 pta ackA triple mutant did not respond to glucose (Fig. 12A, middle and right respectively). Thus, in the absence of
CpxA and in the presence of glucose, cpxP transcription requires both Asp-51 and
AcP.

IN VIVO PHOSPHO-CpxR LEVELS CORRELATE WITH AcP
BUT NOT WITH cpxP TRANSCRIPTION
The simplest explanation for the requirement of both AcP and Asp-51 is that
the CpxA-independent, glucose-induced cpxP transcription requires an AcPdependent phosphorylation of CpxR. Despite this requirement for AcP, the AcP-
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accumulating ackA mutant fails to promote the predicted proportional increase in
cpxP transcription (See Figures 10A, B and 12). To understand this paradoxical
behavior, we assessed whether in vivo levels of phospho-CpxR correlate with those
of AcP in strains WT or mutant for the Pta-AckA pathway.
To monitor phospho-CpxR, I took advantage of a previously reported method
used for the detection of phosphorylated proteins (69, 70), including bacterial response regulators (5, 85). This method uses a dinuclear metal complex (i.e. 1,3-bis
[bis (pyridin-2-ylmethyl) amino] propan-2-olato dizinc [II]) that has affinity for
phosphomonoester dianions, such as the aspartyl phosphate of response regulators.
When included in an SDS-PAGE gel, this phosphate-binding tag (Phos-TagTM) slows
the migration of the phosphorylated protein, allowing it to be distinguished from
the non-phosphorylated protein by mobility shift.
To verify the report that AcP can function in vitro as a phosphoryl donor to
CpxR (101) and to optimize the assay, I incubated purified His6-CpxR with AcP, resolved the proteins by Phos-TagTM SDS-PAGE and stained the gel with SimplyBlueTM
(Invitrogen). I detected an AcP-dependent shift in CpxR migration that disappeared
when the sample was exposed to 95°C for 15 minutes, a condition that induces hydrolysis of phosphorylated aspartyl residues (Fig. 13A).
To test the hypothesis that glucose induces cpxP transcription by increasing
phospho-CpxR concentration, I assessed the cpxR1 mutant (strain PAD292) transformed with plasmids that expressed either His6-CpxR or His6-CpxR D51A. I grew
the transformants in the absence or presence of 0.4% glucose, harvested cells as the
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cultures entered stationary phase, separated the cell lysates by Phos-TagTM SDSPAGE and performed a Western immunoblot analysis with anti-His6 antibody. Consistent with the idea that glucose-induced cpxP transcription requires phosphoCpxR, I detected a glucose- and Asp-51-dependent shift in CpxR that was sensitive to
heat (Fig. 13B).
To test the role of AcP, I performed a similar experiment on cpxR1 ackA
(strain AJW3827, Table 1) and cpxR1 pta ackA (strain AJW3875, Table 1) mutants
transformed with the His6-CpxR expression plasmid. Consistent with the hypothesis
that AcP mediates CpxR phosphorylation, the shifted band was absent in the cells
that cannot synthesize AcP (cpxR1 pta ackA) but present in the cells that accumulate
AcP (cpxR1 ackA) (Fig. 13C).
To facilitate detection of shifted phospho-CpxR, the aforementioned PhosTagTM experiments were performed with cells that overexpressed His6-CpxR. Because I was aware that overexpression of tagged proteins often causes artifacts, I
performed a similar experiment with WT and cpxA mutant cells that expressed WT
CpxR from the native locus. In response to glucose, the phosphorylated fraction of
native CpxR increased substantially, regardless of the status of CpxA (Fig. 13D).
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CONCLUSION
AcP has been proposed to play a role in transcription regulation by serving as
a phosphoryl group donor to several RRs. In this chapter, I tested this hypothesis
using the CpxAR system, which had been proposed previously to be influenced by an
AcP-dependent phosphorylation of the RR CpxR.
My results demonstrate that the addition of glucose, pyruvate and acetate to
TB7 can induce cpxP transcription even in the absence of the cognate sensory protein CpxA. Genetic manipulations of the Pta-AckA pathway and of the CpxAR 2CST
demonstrated that glucose-induced (and to some degree pyruvate-induced) cpxP
transcription requires the Pta-AckA pathway, CpxR and its phosphorylation site,
Asp-51. The simplest explanation to these results is that, in the absence of CpxA and
in the presence of glucose, and likely other carbon sources, AcP can function as the
phosphoryl donor to CpxR, and that this phosphoryl transfer leads to transcription
activation of cpxP. The conclusions derived from my genetic experiments were supported by biochemical data that demonstrate that in vivo phosphorylation of CpxR
requires glucose, AcP and the phosphorylation site, Asp-51. This was the first time
that biochemical evidence demonstrated that a RR is phosphorylated in vivo in an
AcP-dependent manner and showed that the AcP-dependent phosphorylation site is
the same as the one phosphorylated by the cognate sensor kinase-dependent mechanism. While these results make a straightforward case for the transfer of phosphoryl group from AcP to CpxR, the weak response to glucose by ackA mutants, de-
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spite the presence of phosphorylated CpxR, suggests that regulation of cpxP transcription involves more than just CpxR phosphorylation.
In the following chapter, I will address the hypothesis that regulatory mechanisms, other than CpxR phosphorylation, are involved in the CpxA-independent,
glucose-induced cpxP transcription.

CHAPTER FOUR
RESULTS
ACETYLATION AND TRANSCRIPTIONAL REGULATION
In the previous chapter, I provided evidence that supports the hypothesis
that, upon the addition of 0.4% glucose to TB, AcP phosphorylates CpxR in vivo and
that this phosphorylation event impacts cpxP transcription. However, cpxP transcription does not fully correlate with the predicted intracellular concentration of
AcP (64). While I did find that pta ackA double mutants, which do not synthesize
AcP, failed to induce cpxP transcription, ackA mutants (which are predicted to accumulate more AcP than WT) exhibited cpxP transcription below WT levels, even
though CpxR was found to be phosphorylated under the same conditions. This
somewhat paradoxical behavior led me to hypothesize that additional regulatory
mechanism(s) might modulate the CpxA-independent, glucose-induced and AcPdependent cpxP transcription.
Through a series of genetic and biochemical approaches I investigated
whether, in addition to CpxR phosphorylation, other regulatory mechanism could
regulate cpxP transcription. The data that I will present here implicate protein
acetylation in a sophisticated regulatory mechanism that seems to modulate AcPdependent cpxP transcription.
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CATABOLITE REPRESSION
In E. coli and many other bacteria, glucose has a profound impact on central
metabolism, affecting, among other things, the concentration of cyclic-AMP. CyclicAMP is an important transcriptional regulator that modulates the activity of CRP,
the master regulator of E. coli central metabolism. By binding to CRP, cyclic-AMP induces a conformational change that allows CRP to interact with many promoter regions and to regulate their activity. Glucose, however, leads to a decrease in total cyclic-AMP concentration, preventing CRP from binding DNA [reviewed in (144)]. Although there is no evidence that this event (known as catabolite repression) could
affect cpxP transcription via a direct interaction with the cpxP promoter region,
there was no evidence to rule out an indirect effect.
To test whether catabolite repression could influence cpxP transcription, I
exposed cpxA mutants (Strain PAD348 Table 1) to a non-catabolite-repressing carbon source (acetate) and to two catabolite-repressing carbon sources (glucose and
pyruvate), measured β-galactosidase activity and compared the cpxP response to
each of these carbon sources (Fig. 14). Since glucose, pyruvate and acetate induced
similar responses, it is unlikely that catabolite repression plays a substantive role in
regulating cpxP transcription. Therefore, I explored other effects that exposure to
glucose might exert on E. coli physiology.
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GLUCOSE AND AcP AFFECT GLOBAL PROTEIN ACETYLATION
Besides lowering cyclic-AMP levels, glucose rapidly increases the AcCoA concentration in E. coli (21) and, recently, it has been shown to promote protein acetylation in S. enterica (139). S. enterica, however, is not the only bacterial species
where protein acetylation occurs; global proteomic studies using mass spectrometry analysis have demonstrated that protein acetylation is common also in E. coli
and B. subtilis (68). The studies in E. coli identified acetylated proteins that are part
of many physiological processes. Of great interest to me was evidence that some of
the RNA polymerase subunits (α, β and β’) could be acetylated. Therefore, I considered the possibility that, in addition to protein phosphorylation, an acetylation event
could influence cpxP transcription.
To test this hypothesis, I first asked whether, similarly to S. enterica, global
protein acetylation in E. coli could be affected by the addition of glucose to the
growth medium. To that end, I used a cocktail of two polyclonal anti-acetyllysine antibodies to perform Western immunoblot analysis on whole cell lysates from cpxA
mutant cells grown either in TB7 supplemented with 0.4% glucose or not (Fig 15).
As reported for S. enterica (139), the presence of glucose resulted in a general increase in the acetylome, as detected by the increase in number and/or intensity of
acetylated bands. Subsequently, these results were verified and extended by Bozena
Zemaitatis (a Research Specialist in our laboratory), who optimized the antiacetyllysine Western immunoblot analysis, and quantified by our collaborators Birgit
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Schilling and Bradford Gibson (Buck Institute for Aging, Novato, CA), who used a
novel mass spectrometric approach.
To determine whether glucose enhanced the acetylome, Bozena grew
MC4100 strains in TB7 and TB7 supplemented with 0.4% glucose, harvested cells at
5 time points over the course of two days (OD600 = 0.5 and 1.0 and 8, 24 and 32
hours), prepared cell lysates, and subjected them to anti-acetyllysine Western immunoblot analysis (Fig. 16B). While she observed more bands across the entire
growth curve under both growth conditions, Bozena came to the same general conclusion: glucose enhances the WT acetylome. These results were verified and quantified by Drs. Schilling and Gibson, who applied mass spectrometry analysis to
whole cell lysates from WT cells grown in TB7 or in TB7 supplemented with 0.4%
glucose to OD600 = 1.0. In the absence of glucose, they detected 414 unique acetyllysines in 194 proteins in the WT parent. In presence of glucose, they detected 965
unique acetylation sites in 368 proteins. Thus, glucose enhances both the number of
acetylations and the number of acetylated proteins.
To determine if the Pta-AckA pathway could affect protein acetylation,
Bozena also performed anti-acetyllysine Western immunoblot analysis on cell lysates from ackA and pta ackA double mutants grown over two days in TB7 (without
glucose supplementation). Relative to its WT parent, the ackA mutant was hyperacetylated, especially during exponential growth (Fig. 16A). In contrast, the acetylome of the pta ackA mutant more closely resembled that of its WT parent. These
data suggested that the enhanced acetylation exhibited by the ackA mutant was due
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to the accumulation of AcP, but it also could be a direct result of the enzyme Pta. To
distinguish between these two hypotheses, Bozena tested a pta mutant (which retains AckA and thus the ability to accumulate AcP when exposed to exogenous acetate). When cells were grown in TB7 supplemented with 10 mM acetate, the acetylome was considerably more robust (Fig. 16C). Taken together, these data implicate
AcP as a regulator of acetylation. Since growth in the presence of glucose not only
increases the concentration of AcCoA, but also that of AcP (64), Bozena asked
whether glucose-induced acetylation required AcP. Indeed, the increased acetylation exhibited by WT cells when grown in TB7 supplemented with glucose was
completely absent in the pta ackA mutant (Fig. 16B). These results were verified by
mass spectrometry. In the absence of glucose, our collaborators detected 414 acetylation sites in 194 proteins from WT lysates, 932 acetylation sites in 379 ackA proteins from ackA mutant lysates, but only 225 acetylation sites in 125 proteins from
the pta ackA mutant. In the presence of glucose, mass spectrometry detected 965
acetylated sites in 368 proteins from the WT parent but 2150 unique acetylation
sites in 664 proteins from whole cell lysates derived from the ackA mutant. They did
not analyze the pta ackA mutant grown in the presence of glucose.
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Among some of the proteins identified as differentially acetylated between
WT and ackA mutants are all of the subunits of RNA polymerase. If RNA polymerase
is indeed acetylated, one could imagine that its acetylation could affect transcription
of many E. coli promoters, including cpxP. Therefore, I hypothesized that RNAP acetylation affects the CpxA-independent, AcP-dependent cpxP transcription.
To verify that RNAP subunits are indeed acetylated, I grew the cpxA mutant
and cpxA ackA double mutant (strain AJW 2794, Table 1) in the presence or absence
of glucose, purified RNAP subunits α, β and β’ by immunoprecipitation, and sent the
purified proteins to another collaborator (Dr. Haike Antelman) for mass spectrometry analysis.
From ackA cells grown in the presence of glucose, Dr. Antelmann and her
group mapped 19 acetylation sites to β (Table 2), of which 12 were detected in at
least two biological replicates. They mapped an additional 6 acetylation sites to β’, of
which 4 were detected in two biological replicates (Table 2). And finally, they
mapped 7 acetylation sites to α, of which 4 were detected in two biological replicates (Table 3, Fig. 17). None of the reproducibly acetylated α sites was acetylated
when ackA cells were grown in the absence of glucose (Tables 2 and 3). Dr. Antelmann’s group also detected glucose-dependent acetylation on RNAP subunits purified from WT cells, but the acetylation sites differed from those detected in the ackA
mutant (Table 4). I will first describe my efforts to determine if acetylation could be
responsible for the weak response to glucose exhibited by ackA mutants. Later, I will
describe my investigation into the role that RNAP acetylation plays in WT cells.
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LYS-291 ON RNAP αCTD CONTRIBUTES TO TRANSCRIPTION INHIBITION
To test the hypothesis that the weak response to glucose by ackA mutants
requires one of the acetylated lysines of RNAP, I used site-directed mutagenesis to
convert the acetylated lysines to alanine; therefore, preventing their acetylation. Because the gene that encodes α (rpoA) is essential for bacterial survival, I used a previously reported partial-diploid system (39) to test the hypothesis that one of the
acetylated lysines on α inhibits cpxP transcription. This system keeps the WT copy
of rpoA at its native site in the chromosome, and introduces mutant rpoA alleles into
the cell via a multi-copy plasmid allowing one to determine if any given residue on α
is involved in a particular behavior.
Into an ackA cpxA Φ(PcpxP’-lacZ) lysogen that carries the WT rpoA gene in its
native location on the chromosome (strain AJW2794), I introduced plasmids carrying either the WT rpoA allele or K-to-A point mutation derivative alleles (Table 1)
with the goal of determining if any lysine functional group contributes to the weak
response to glucose. I grew the resultant transformants in the absence or presence
of 0.4% glucose and monitored β-galactosidase activity. cpxA ackA mutant cells that
overexpressed the α K291A mutant responded robustly to the presence of glucose.
In contrast, we observed little or no response from cpxA ackA mutants that overexpressed WT α, K-to-A mutations of the other 4 lysines of the αCTD (Fig. 18A) or Kto-A mutations of the 3 acetylated lysines on the αNTD (data not shown).
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I also investigated whether Lys-291 could be responsible for the low cpxP
response to 4% glucose in cpxA mutant cells (strain PAD348) whose Pta-AckA
pathway remains intact. Indeed, cells that overexpressed the K291A variant yielded
a stronger response to the presence of 4% glucose than did cells that overexpressed
WT α (Fig. 18B). In contrast, Lys-291 was not required for the response to 0.4%
glucose, as cpxA mutant cells that overexpressed either WT α or the K291A mutant
responded at the same intensity (Fig. 18C). Therefore, whether caused by excessive
glucose or by disruption of the Pta-AckA pathway, inhibition acts through Lys-291,
perhaps due to its acetylation.
To determine if the requirement for Lys-291 could involve its acetylation, I
took advantage of a genetic strategy commonly used in studies of eukaryotic protein
acetylation (25). In this approach, the lysine (K) is converted to either a glutamine
(Q) or an arginine (R). The KQ substitution mimics the neutral acetylated lysine,
while the KR substitution mimics the positively charged unacetylated lysine. Consistent with the hypothesis that Lys-291 acetylation inhibits glucose-induced cpxP
transcription, cpxA mutant cells overexpressing the K291Q mutant variant of α responded to glucose with less intensity than did cells that overexpressed WT α or its
K291A or K291R mutant variants (Fig. 18C). This decrease in cpxP transcription,
however, cannot be explained by a decrease in steady state levels of the protein,
since I did not observe any difference in their steady-state level (data not shown).
These results lend support to the hypothesis the Lys-291 acetylation decreases the
response to glucose by cpxP.
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IS AN ACETYLTRANSFERASE
REQUIRED FOR THE WEAK RESPONSE TO GLUCOSE?
In eukaryotes, protein acetylation is a reversible post-translational modification that is balanced by the action of a protein acetyltransferase that adds an acetyl
group to the Nε amino group of a lysine, and a protein deacetylase that mediates the
hydrolysis of the acetyl group. Therefore, I hypothesized that Lys-291 acetylation
would require the action of an acetyltransferase and predicted that overexpression
of this acetyltransferase should inhibit cpxP transcription, even when the Pta-AckA
pathway is intact, while deletion of such an acetyltransferase should promote a
strong response to glucose in the ackA mutant.
To identify an acetyltransferase that participates in Lys-291-dependent inhibition of cpxP transcription, I transformed WT cells with a set of multicopy plasmids; each plasmid expressed one of 22 known or predicted E. coli acetyltransferases (Table 1). I grew the resultant transformants in the presence of glucose and IPTG
(to induce acetyltransferase expression), and measured β-galactosidase activity.
Relative to the WT strain carrying the vector control plasmid, overexpression of 8
different acetyltransferases substantially inhibited the glucose response, while
overexpression of only one increased the response (Fig. 19A and data not shown).
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To test if one of these acetyltransferases was required for the weak response to glucose by the ackA mutant, I deleted each acetyltransferase from the ackA mutant
(strain AJW3994) and screened for double mutants whose cpxP promoter could respond strongly to glucose. Only the ackA wecD double mutant exhibited strong cpxP
transcription (Fig. 19B). However, this expression is unlikely to involve Lys-291
acetylation as it occurred even in the absence of glucose (Fig. 19B inset).
On the basis of these results, I concluded that multiple acetyltransferases
could inhibit glucose-induced cpxP transcription, but that no single tested acetyltransferase may be required for this inhibition.

K291Q ALSO AFFECTS cpxP TRANSCRIPTION IN VITRO
The observed decrease in glucose-induced cpxP transcription, when I overexpressed several acetyltransferases, supports the hypothesis that protein acetylation can inhibit cpxP transcription. This hypothesis is also supported by the decrease in transcription when Lys-291 of α was substituted by a glutamine, which is
thought to be a genetic mimic of an acetylated lysine. However, it remained unclear
whether this potential effect of protein acetylation was a direct or indirect effect on
the glucose-induced cpxP transcription. To distinguish between these two possibilities, I sought to first reconstitute cpxP transcription in vitro and then ask whether α
K291Q had any effect in the in vitro transcription system.
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To establish the in vitro transcription system, I combined purified WT RNA
polymerase containing σ70 (Eσ70) with purified WT or D51A CpxR, purified plasmid
p770 carrying a DNA fragment that includes the cpxP promoter (Table 1) and AcP in
an in vitro transcription buffer. The reactions were incubated at 30°C for 15
minutes and transcription was visualized by incorporation of [32P]-labeled UTP into
the transcripts. To the extent that I tested, in vitro transcription of cpxP seems to
have the same requirements as its in vivo transcription: AcP (Fig. 20), CpxR (Fig.
21), and Asp-51 (Fig. 22) the phosphorylation site of CpxR. These results support
the use of this system to test whether the effect of α K291Q on cpxP transcription is
a direct or indirect effect. To that end, I combined purified RNAP that contained
αK291Q with purified WT CpxR, purified p770 carrying cpxP and AcP in an in vitro
transcription buffer. The reactions were incubated at 30°C for 15 minutes and transcription was visualized by incorporation of [32P]-labeled UTP into the transcripts.
When compared to WT, RNAP that contained αK291Q was defective for cpxP transcription. This defect in transcription, however, does not seem to affect the overall
function of RNAP as rna1 transcription, which does not require the αCTD, seemed
unaffected by the mutation at Lys-291 (Fig. 23).
The αCTD is an important transcription regulator and it does so by directly
interacting with that UP element, an AT-rich region found in some but not all promoters, and/or by directly interacting with transcription factors; in either case, the
αCTD is thought to aid in the recruitment of the holoenzyme to the promoter region.
Therefore, if αK291Q could somehow lead to a misfolded domain, this mutation
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could affect virtually any promoter that requires the αCTD for proper regulation.
However, this mutation could have more specific and targeted effects; for example,
if the αK291Q does not cause any general folding defect.
To distinguish between these two possibilities, I took advantage of the large
amount of molecular information available on the interaction between αCTD and
the ribosomal RNA promoter rrnB. Proper transcriptional regulation of rrnB requires the αCTD, but there is no evidence that Lys-291 plays any role in this regulation. Therefore, I predicted that if the defect in in vitro cpxP transcription, as seen
with αK291Q, was due to improper CTD folding, then it also should affect rrnB transcription in vitro. However, if αK291Q was able to properly fold its CTD, then rrnB
transcription should not be affected, as αK291 is not involved in rrnB transcription.
Consistent with the idea that αK291Q is capable of properly folding its CTD, there
was no visible difference in rrnB in vitro transcription between reactions with WT
RNAP and those with αK291Q RNAP.
On the basis of these results, I conclude that substitution of glutamine for lysine at position 291 of α has a direct effect on cpxP transcription. Additionally, this
defect seems to be specific to cpxP, as this substitution does not affect transcription
of the rrnB promoter, which has been shown to require the αCTD, but not Lys-291.
Since glutamine is considered a mimic of acetylated lysine and since Lys-291 is
acetylated in the ackA mutant, I propose that acetylation of Lys-291 is responsible
for the weak cpxP transcription observed in the ackA mutant.
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CONCLUSION
I previously demonstrated that AcP could function as a phosphoryl donor,
both in vitro and in vivo, to the RR CpxR. However, I hypothesized that this transfer
of phosphoryl group was not the only regulatory mechanism involved in the CpxAindependent, glucose-induced cpxP transcription. I had come to this hypothesis because ackA mutants failed to induce high cpxP transcription in response to the addition of glucose, even though CpxR was phosphorylated under these conditions.
Thus, the goal of this chapter was to test the hypothesis that, in addition to CpxR
phosphorylation, additional a regulatory mechanism(s) control(s) cpxP transcription. The data presented here dismiss catabolite repression and implicate protein
acetylation as that additional regulator, perhaps via Lys-291 of α.
With the help of Dr. Antelmann and her group, we determined that RNAP
acetylation was enriched when WT and ackA mutant cells were grown in TB7 supplemented with 0.4% glucose relative to unsupplemented TB7. The acetylated lysines from both WT and ackA mutant samples were distributed throughout the
RNAP subunits that we analyzed. However, the distribution was different in the two
different strains. In each strain, some of the acetylations were located near sites that
could impact RNAP function (i.e. the DNA binding patch of the αCTD and near the
secondary channel between β and β’). This lends credence to the idea that acetylation could regulate activity. I tested this concept by converting each of the acetylated
lysines of α to an alanine and learned that Lys-291 was involved in the weak response to 0.4% glucose by the ackA mutant and in the response to 4% glucose by

91
the WT parent. Furthermore, conversion of lysine 291 to the acetylated lysine mimic
glutamine (K291Q) inhibited cpxP transcription both in vivo and in vitro. Although
the finding that αK291 is involved in dampening cpxP transcription when WT cells
are exposed to 4% glucose leads me to hypothesize that Lys-291 involvement in the
4% response is due to its acetylation, this hypothesis remains to be tested and at
this point we do not have mass spectrometry evidence that Lys-291 becomes acetylated in the presence of 4% glucose.
If the K291Q substitution is a true mimic for acetylation of that residue, then
the K291Q inhibition of cpxP transcription is evidence that RNAP acetylation directly impacts cpxP transcription, dampening it when compared to unacetylated RNAP.
The effect of Lys-291 acetylation, however, does not seem to affect all αCTDdependent promoters, as the well characterized rrnB promoter was unaffected by
αK291Q, even though its transcription requires the αCTD.
The mechanism by which K291 becomes acetylated in the ackA mutant background remains unknown. Overexpression of several known and putative acetyltransferases inhibited cpxP transcription in cells with an intact Pta-AckA pathway,
yet deletion of no single acetyltransferase was sufficient to relieve the inhibition of
cpxP transcription observed in ackA mutants. It is possible that multiple acetyltransferases could acetylate K291. Alternatively, acetylation of this residue might occur in
a manner that does not require an acetyltransferase. This issue will be address in
the next chapter.
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Although Lys-291 of α was the only tested lysine involved in cpxP transcription, β and β’ are also widely acetylated. This raises the possibility that some of
these acetylation events could also affect transcription. Additionally, α, β and β’
were also found to be acetylated even when the Pta-AckA pathway was intact, albeit
on different residues, as long as the cells were grown in the presence of glucose.
This raises the question: could any of these acetylation events of RNAP from WT
cells also affect transcription from cpxP or from other promoters? This question will
be addressed in the next chapter.

CHAPTER FIVE
RESULTS
ACETYLPHOSPHATE AS AN ACETYL DONOR
I previously showed evidence that transcription of the cpxP promoter can be
regulated both by the canonical CpxA-dependent phosphorylation of CpxR and by a
CpxA-independent mechanism, via an AcP-dependent phosphorylation. I also provided evidence to support the hypothesis that this AcP-dependent behavior is
modulated by acetylation of Lys-291 on the αCTD of RNAP. Acetylation of α Lys-291
was detected when ackA mutant cells were grown in the presence of 0.4% glucose.
Thus, I proposed that RNAP acetylation is a novel regulatory mechanism of the cpxP
promoter. However, we also detected RNAP acetylation in WT cells that contained
an intact Pta-AckA pathway. These observations raise the possibility that some of
these WT acetylation events affect RNAP function. In this chapter, I will ask if glucose-induced cpxP transcription can be affected by protein acetylation when the
cells contain an intact Pta-AckA pathway.

93

94

cpxP TRANSCRIPTION RESPONDS TO ALTERATIONS IN THE ACETYLOME
To test the hypothesis protein acetylation affects cpxP transcription in WT
cells, I exposed the cpxA mutant (strain PAD348) to increasing concentrations of nicotinamide, an inhibitor of NAD+-dependent sirtuin-like protein deacetylases. If protein acetylation influences cpxP transcription in WT cells, I would expect that this
transcription would be affected by the addition of nicotinamide to the media. In support of the hypothesis that cpxP transcription is affected by protein acetylation, I observed a CpxA- and glucose-independent increase in cpxP transcription that increased as the concentration of nicotinamide increased, achieving more than a 4-fold
induction at 50 mM nicotinamide, even in the absence of glucose (Fig. 24A).
Since nicotinamide can induce CpxA-independent cpxP transcription and glucose can induce protein acetylation, I hypothesized that the glucose-induced cpxP
transcription could involve protein acetylation. To test this hypothesis, I overexpressed the NAD+-dependent deacetylase CobB (pCA24n-cobB; Table 2) in WT cells
(strain PAD282) grown in the presence of 0.4% glucose. If the cpxP response to glucose requires protein acetylation, then cells that overexpress CobB should respond
less strongly to glucose when compared to vector control. Indeed, overexpression of
CobB reduced the 6-fold glucose-dependent induction to a more modest 3-fold induction (Fig. 24B).
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To determine whether the above mentioned treatments could influence the
overall protein acetylation pattern, I used a cocktail of two polyclonal antiacetylated-lysine antibodies to detect overall protein acetylation via Western immunoblot analysis of whole cell lysates (Fig. 15). When WT cells (strain PAD282)
were grown in the presence of either nicotinamide or glucose, the acetylome changed
relative to cells grown without treatment. Glucose generally caused the number
and/or intensity of acetylated bands to increase, as reported previously in chapter 3.
In contrast, the deacetylase inhibitor nicotinamide induced more subtle changes.
These subtle changes in the acetylation pattern correlated with a weaker response by
the cpxP promoter to the addition of nicotinamide when compared to its response to
glucose. CobB overexpression in cells exposed to glucose yielded a strong effect on
the acetylation pattern. This acetylome closely resembled that of cells grown in the
absence of glucose or nicotinamide. Thus, the conditions that influence cpxP transcription correlate with a change in the E. coli acetylome.

GLUCOSE-INDUCED cpxP TRANSCRIPTION
REQUIRES A LYSINE ACETYLTRANSFERASE
In S. enterica, the NAD+-dependent deacetylase CobB works in conjunction
with the GCN5-like acetyltransferase Pat to regulate the activity of the enzyme acetyl-CoA synthetase (124, 125). The finding that CobB overexpression could inhibit
cpxP transcription led us to hypothesize that glucose-induced cpxP transcription
could be regulated by the E. coli Pat homolog, YfiQ.

97

98
To test the hypothesis that YfiQ regulates glucose-induced cpxP transcription,
I compared the glucose response of a mutant that lacks YfiQ (strain AJW3143; Table
1) to that of its WT parent (strain PAD282). In contrast to its WT parent (approximately 3.5-fold induction), the yfiQ mutant responded poorly to glucose (approximately 1.5-fold induction) (Fig. 25). The requirement for YfiQ, however, did not extend to CpxA-dependent cpxP transcription, as surface-induced cpxP transcription
was equivalent in both the yfiQ mutant and its WT parent (data not shown). Thus,
the requirement for YfiQ is specific for the response to additional carbon. Therefore,
I proposed that YfiQ and CobB catalyze the reversible acetylation of a protein, and
that acetylation is required for glucose-induced cpxP transcription.
YfiQ and CobB are known to catalyze the reversible acetylation of acetyl-CoA
synthetase (Acs) (124, 125). To test if Acs was involved in glucose-induced cpxP
transcription, I deleted its gene; however, I did not observe any effect on cpxP transcription (data not shown). This result was not surprising since acs transcription is
inhibited by catabolite repression (73). I therefore sought the cpxP-relevant target
of YfiQ and CobB elsewhere.

YfiQ IS REQUIRED FOR IN VIVO ACETYLATION OF MULTIPLE LYSINES ON RNAP
The finding that protein acetylation was required for glucose-induced cpxP
transcription, that RNAP is acetylated when WT cells is grown in the presence of
glucose, and that acetylation of lys-291 of α seems to inhibit glucose-induced cpxP
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transcription in the ackA mutant, led me to begin my search for the acetylation target(s) of YfiQ by asking whether glucose-induced RNAP acetylation required YfiQ.
To that end, I grew WT and yfiQ mutant cells (strain AJW3143) in the absence or
presence of 0.4% glucose, isolated the RNAP subunits by immunoprecipitation and
subjected them to MS analysis. Using linear trap quadrupole (LTQ) Orbitrap mass
spectrometry (MS), Dr. Haike Antelmann and her group first identified the acetylation sites on RNAP purified from WT cells. They mapped 15 glucose-dependent
acetylation sites to β (Table 4), 11 acetylation sites to β’ (Table 4), and 2 acetylation sites to α (Fig. 26). None of these sites were acetylated when WT cells were
grown in the absence of glucose. Of the 15 different acetylation sites detected from
β, they detected 14 in at least two biological replicates. Of the 11 acetylation sites
detected from β’, they reproducibly detected 8 (data not shown). Finally, α peptides
containing acetylated Lys-297 or acetylated Lys-298 were detected in multiple biological replicates. Ten of the fifteen glucose-dependent β acetylations, ten of the
eleven glucose-dependent β’ acetylations, and one of the two glucose-dependent α
acetylations (Lys-298) required YfiQ (Table 4). Dr. Antelmann’s group detected no
acetylated peptides from yfiQ mutant cells grown in the absence of glucose, which
parallels the results with RNAP isolated from WT cells grown in the absence of glucose. Thus, I conclude that YfiQ is required for most of the glucose-induced acetylations of RNAP in vivo.
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GLUCOSE-INDUCED TRANSCRIPTION REQUIRES LYS-298 OF THE αCTD
That acetylation of several lysines on RNAP is both glucose and YfiQdependent led me to hypothesize that at least one of these residues could be required for glucose-induced cpxP transcription. To test this hypothesis, I focused my
attention on α. I chose α due to its smaller size relative to β and β’, to our finding
that acetylation of only one residue (Lys-298) was both glucose and YfiQ-dependent
and to the finding that, under different conditions, an acetylatable α residue (Lys291) influences cpxP transcription. To test whether Lys-298 or any of the other four
lysines on the αCTD were required for glucose-induced cpxP transcription, I introduced plasmids that carry either the WT rpoA allele or lysine-to-alanine mutant derivatives into the cpxA mutant (strain PAD348), which carries the WT rpoA gene at
its native location on the chromosome. I grew the resultant transformants in the absence or presence of 0.4% glucose and compared the β-galactosidase activity of cells
expressing each lysine-to-alanine substitution to that of cells expressing WT α. Of
the five mutants tested, only K298A exerted a defect on glucose-induced cpxP transcription (Fig. 27A).
To ensure that the K298A mutant retained function, I tested if a CpxAdependent stimulus (i.e., exposure to alkaline pH) could induce cpxP transcription in
cells WT for CpxA (strain PAD282). Indeed, cells expressing the K298A mutant activated cpxP transcription when grown in TB buffered at pH 7.8, but not in TB buffered at pH 7.0 and supplemented with glucose. In contrast, cells expressing WT rpoA
activated cpxP transcription under both conditions (Fig. 27B).
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I further tested whether the loss of glucose-induced cpxP transcription observed with the K298A mutant was due to a dominant-negative effect by measuring
β-galactosidase activity of cells that carried a mutant α lacking its CTD. Into the cpxA
mutant (PAD348), I introduced plasmids that carry either the WT rpoA allele or a
mutant derivative with the CTD and the linker region deleted. I grew resultant
transformants in the absence or presence of glucose and measured β-galactosidase
activity. Like the K298A mutant, the αCTD deletion mutant exhibited a defect in glucose-induced cpxP transcription (Fig. 27C). I interpreted these results to mean that
K298A allele encodes a functional form of αCTD and that Lys-298 is required for
glucose-induced cpxP transcription, but not for CpxA-induced transcription, perhaps
because Lys-298 needs to be acetylated under these conditions.

YfiQ DOES NOT ACETYLATE RNAP IN VITRO
The finding that YfiQ and Lys-298 of α were required for glucose-induced
cpxP transcription and that YfiQ was required for Lys-298 acetylation in vivo, led me
to hypothesize that YfiQ directly acetylated Lys-298. To test this hypothesis I attempted to acetylate α by incubating purified His6-YfiQ, [14C]-labeled AcCoA, and
Eσ70 into the in vitro transcription buffer for 1 hour at 37°C. However, in spite of my
efforts, I was unable to obtain any evidence that YfiQ acetylated α, or any other
RNAP subunit, under my experimental conditions. This raises that possibility that
RNAP is not directly acetylated by YfiQ.
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AcP AS AN ACETYL DONOR
My inability to acetylate RNAP in vitro using YfiQ as the acetyltransferase and
AcCoA as the acetyl donor, led me to consider the possibility that YfiQ does not directly acetylate RNAP and that the observed effect on in vivo RNAP acetylation,
when YfiQ was deleted, was an indirect effect.
Several factors led me to consider the possibility that AcP itself was the acetyl donor to RNAP. (i) Western immunoblot analysis conducted by Bozena
Zemaitaitis and quantitative mass spectrometry performed by Birgit Schilling in
Bradford Gibson’s lab (Buck Institute of Aging) demonstrated that the accumulation
of intracellular AcP correlates with a dramatic increase in total protein acetylation.
(ii) Linda Hu (from our lab) possesses evidence that the central metabolite protein
LpdA can be acetylated in vitro in an AcP-dependent and acetyltransferaseindependent manner. (iii) Misty Kuhn and Michael Scholle from the labs of Wayne
Anderson and Milan Mrksich (Northwestern University) possess evidence that AcP
can function as a direct acetyl donor to linear peptides containing a lysine.
To test if AcP could function as an acetyl donor to RNAP, I incubated Eσ70 in
in vitro transcription buffer with increasing concentration of AcP at 30°C for 1 hour
and detected RNAP acetylation via Western immunoblot analysis. Consistent with
the hypothesis that AcP can function as an acetyl donor to RNAP, I detected an increase in the acetylation of β and/or β’ as the concentration of AcP in the reaction
increased. This result could help explain a conundrum that in vivo cpxP transcription
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requires an acetylation event; however, in vitro transcription occurs in the absence
of an acetyltransferase or AcCoA (Fig. 28).

CONCLUSION
There are over 300 known posttranslational modifications (143). Protein
phosphorylation is likely the most studied of all these posttranslational modifications. However, in the recent years, protein acetylation has been gaining increased
attention in all domains of life. Based on global proteomics studies [(68, 139, 155,
157) and Schilling, Gibson and Wolfe, unpublished], protein acetylation is likely to
affect many proteins that play important roles in E. coli and S. enterica physiology. In
E. coli, some of these proteins are the subunits of RNAP.
In chapter 4, I provided evidence that supports the hypothesis that acetylation of Lys-291 of the α subunit of RNAP inhibits glucose-induced cxpP transcription
in ackA mutants. In this chapter, I extended the effect of protein acetylation and
perhaps of RNAP acetylation to include glucose-induced cpxP transcription from
cells that contain a WT Pta-AckA pathway.
Mass spectrometry analysis conducted by Dr. Haike Antelmann’s group
demonstrated that glucose-induced acetylation of several lysines on α, β and β’ required the acetyltransferase YfiQ. Among the sites affected by deletion of yfiQ is Lys298 of α and conversion of Lys-298 to an alanine had profound impact in glucoseinduced cpxP transcription. YfiQ is also required for glucose-induced cpxP transcription. Thus, together these data support the hypothesis that glucose-induced cpxP

106
transcription is dependent on the YfiQ-dependent acetylation of α Lys-298. Lys-298
is important also for transcription of the rRNA promoter rrnB. At the rrnB promoter
Lys-298 makes direct contact with the DNA backbone. Thus, acetylation of this residue could potentially have broad impact in E. coli physiology.
Despite being required for acetylation of approximately 70% of the lysines
acetylated by glucose, including Lys-298, I was unable to obtain in vitro evidence
that YfiQ directly acetylates any of those lysines. This raises the possibility that the
YfiQ effect on RNAP acetylation is indirect. In fact, my data indicate that AcP is more
likely to be directly responsible for RNAP acetylation than YfiQ, as I was able to detect, by Western immunoblot analysis, an increase in acetylation of β and/or β’
when RNAP was incubated with increasing concentration of AcP. Additional analysis, via mass spectrometry, is required to determine if other RNAP subunits are also
acetylated by AcP and if so their identity.
AcP had previously been proposed to play an important role in E. coli physiology due to its ability to donate its phosphoryl groups to some response regulators
in vitro. In chapter 3, I demonstrated that this transfer of phosphoryl group from
AcP to RRs also occurs in vivo to the RR CpxR. However, based on evidence presented in this chapter, this AcP-dependent phosphorylation seems to be modulated by
another AcP-dependent posttranslational protein modification, the acetylation of
RNAP. This acetylation sees to function in some sort of balancing acting, modulating
the strength of the AcP-dependent cpxP transcription.
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The E. coli genome is predicted to encode over 20 known or putative Gcn5like acetyltransferases. Of those, YfiQ is likely the best characterized, and is the only
one to be demonstrated to possess Nε lysine acetylation capabilities. However, global mass spectrometry analysis performed by Birgit Schilling and Bradford Gibson
detected only a 10-20% reduction in the total number of proteins acetylated when
yfiQ was deleted from E. coli cells grown in the presence of 0.4% glucose. In contrast,
deletion of ackA doubled the number of acetylated proteins, under the same conditions, and deletion of both pta and ackA decreased the number of total acetylated
proteins by 50% in the absence of glucose. Thus, I concluded that, under the tested
condition, AcP has a more important role in protein acetylation than the acetyltransferase YfiQ. This effect is likely to be a combination of direct and indirect acetylation
as transcription of the putative acetyltransferase YafP is increased in cells that accumulate AcP and AcP can serve as the acetyl donor for at least two proteins in vitro,
LpdA and RNAP.

CHAPTER SIX
DISCUSSION
OVERALL SUMMARY
As part of the long-term effort by the Wolfe laboratory to map the impact of
AcP on the network of E. coli 2CST pathways, I discovered that AcP has a significant
effect on CpxR-dependent transcriptional regulation of cpxP. The evidence I presented here supports a model in which AcP plays a pivotal role in the transcription
regulation of cpxP via both phosphorylation of the RR CpxR and acetylation of RNAP.
These two PTMs seem to work together to fine tune cpxP transcription as the intensity of the AcP-dependent cpxP transcription seems to be affected by acetylation of
different lysine residues on the αCTD. While the hypothesis that AcP can phosphorylate and therefore control the activity of multiple response regulators has been proposed before (90, 91), the notion that AcP can also serve as an acetyl donor is fairly
novel. This newly identified role for AcP has the potential to open several new lines
of investigation. Some questions come to mind: What is the overall impact of this
AcP-dependent acetylation? It seems evident that RNAP acetylation has the potential to affect multiple aspects of E. coli physiology. How many more proteins are
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acetylated in the same manner? Some recent data from the Wolfe laboratory
demonstrate that AcP has a large impact on the overall protein acetylation status of
E. coli, as demonstrated by Western immunoblot analysis and mass spectrometry
analysis. How prevalent is AcP-dependent acetylation when compared to AcCoAdependent acetylation? Does AcP-dependent acetylation occur in other organisms?
The Wolfe laboratory has started to address some of these questions and,
based on some of the data obtained so far, it seems like AcP has a broader impact in
E. coli physiology than previously appreciated.

SIGNAL INTEGRATION
On the basis of my observations and previously published reports, I propose
that the CpxAR pathway integrates multiple signals at three distinct levels. (i) In the
periplasm, CpxP integrates stimuli predicted to cause misfolding of envelope proteins [for reviews, see references (31, 32, 106, 115)]. (ii) At the cytoplasmic membrane, the periplasmic domain of CpxA integrates information concerning the status
of the periplasmic chaperone CpxP with signals that depend on the outer membrane
lipoprotein NlpE and with stimuli that depend on neither CpxP nor NlpE (11, 30, 98,
107, 110, 151). (iii) Finally, in the cytoplasm, CpxR integrates the above mentioned
CpxA-dependent signals with those that are independent of CpxA (e.g., entry into
stationary phase and exposure to excess carbon (23, 149).
It has been reported previously that entry into stationary phase generates a
CpxA-independent response (11, 14). The nature of the response, however, has re-
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mained elusive. The response of cells grown in glucose minimal media buffered with
phosphate depends in part on σS (28), while the response of cells grown in LB does
not (30). Like LB, TB is based on tryptone. Furthermore, σS is not fully functional
this early in the transition to stationary phase, at least during growth in LB (142).
Finally, deletion of both CpxA and the Pta-AckA pathway reduced growth-dependent
cpxP activity to levels that resembled those of cpxR mutants (Fig. 5A). Thus, as cells
enter stationary phase, cpxP becomes activated in response to both CpxA-dependent
and Pta-AckA-dependent stimuli. This raises an intriguing question. During normal
growth in a tryptone-based broth, why and how would CpxRA signaling respond to
both envelope-associated and growth-associated cues?
Cells experience multiple stimuli that impact the phosphorylation status of
RRs, including CpxR. Thus, the CpxR-dependent behavior of WT cells represents an
integration of all these stimuli, and efforts to dissect this and other complex pathways must take this into account.
It is difficult to imagine that this complex signal integration is a privilege of
the CpxAR pathway. In fact, evidence from the Wolfe laboratory suggests that at
least one other 2CST pathway, the Rcs (Regulator of Capsule Synthesis) phosphorelay, also possesses a highly intricate and sophisticated mechanism to integrate signals that originate from the outer and inner membranes, periplasm and cytoplasm.
The Rcs phosphorelay activates genes required for capsular biosynthesis (47) and
multiple stresses (10, 26), while repressing genes required for flagellar biogenesis
(37). Published evidence demonstrated that the RR RcsB can be both phosphory-
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lated and acetylated, and that both modifications can affect the function of this protein (38, 130). RcsB phosphorylation can occur via the canonical SK-dependent
phosphorylation or via an AcP-dependent mechanism (38, 146). Parallel to what I
demonstrated for CpxR, multiple observations support the hypothesis that AcPdependent RcsB phosphorylation occurs on the conserved Asp residue that functions as the phosphoacceptor for sensor kinase-dependent phosphotransfer (Hu, L.
I. and Wolfe, A. J. unpublished data). It is the acetylation of RcsB that seems to challenge all previously established rules and concepts regarding protein acetylation. In
vitro, acetylation can occur via an YfiQ-dependent transfer of the acetyl group from
AcCoA to Lys-180 of the DNA-binding motif of RcsB (130). In vitro, however, the
transfer of acetyl groups from AcCoA to RcsB also seems possible in the absence of
any acetyltransferase (Hu, L. I. and Wolfe, A. J. unpublished data); this mechanism
might be similar to the autoacetylation processes proposed for ACS and CheY (4). An
additional autoacetylation mechanism seems to use AcP as the acetyl donor, Linda
Hu possesses evidence that LpdA can be acetylated using acetyl groups from AcP
and I demonstrated that the same can occur to RNAP (Chapter 5). In fact, recent data
from the Wolfe laboratory demonstrate that AcP has a large impact on the overall
protein acetylation status of E. coli (Bozena Zemaitaitis and Alan J. Wolfe, unpublished data). It remains to be determined how much of this impact is direct, as
seems to be the case for RNAP and LpdA acetylation, and how much of the impact is
indirect.
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THE LOSS OF THE Pta-AckA PATHWAY
Disruption of the Pta-AckA pathway is likely to have many effects in E. coli
metabolism and therefore the overall physiology of the cell. The Pta–AckA pathway
does more than simply synthesize AcP. During acetogenesis, this pathway recycles
CoA, generates ATP, and evolves acetate [reviewed in (144)]. E. coli produces limiting amounts of CoA; therefore, cells must recycle CoA to maintain glycolytic flux, and
loss of the Pta-AckA pathway removes their “favored” option, at least at neutral pH,
potentially leading to accumulation of AcCoA [review in (144)].
In many respects, mutants that lack AckA or both Pta and AckA behave similarly. In batch culture, they excrete little or no acetate, and they limit their production of ethanol. Instead, they both excrete pyruvate, lactate, and glutamate, a behavior that might be explained by the observation that these mutants exhibit increased
expression and activity of key glycolytic and TCA cycle enzymes [reviewed in
(144)]. Surprisingly, they do not increase expression of their CoA biosynthetic machinery (148), nor do they alter their AcCoA pool relative to that of their WT parent
(72). The increased expression and activity of both glycolytic and TCA cycle enzymes and the altered excretion profile suggest that cells attempt to compensate for
the loss of the Pta-AckA pathway (148). This loss of the pathway by the cells and
their attempt to compensate for it can make the interpretation of some phenotypes
associated with AcP a little challenging. In fact, some studies provide some evidence
for pathway involvement but fail to make a strong connection to AcP [for a review,
see reference (145)]. Similarly to what I found for CpxAR signaling, some further in-
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vestigation of these pathways may discover new mechanisms that involve more
than just AcP-dependent phosphorylation of RRs and might also involve more than
just 2CST.

AcP-DEPENDENT PHOSPHORYLATION
Plenty of evidence exists that AcP can readily phosphorylate RRs in vitro
(144). In vivo, AcP-dependent behaviors have been reported in diverse bacteria, including pathogens [for example, (99, 150)]. In E. coli for example, the regulation of
about approximately 100 genes correlates with the status of AcP (148). However,
the evidence for a transfer of phosphoryl group from AcP to some RR, in many cases,
is either weak or nonexistent [reviewed in (146)]. Some of the challenges in demonstrating the role of AcP as a global signaling molecule comes from the pivotal role
AcP plays in central metabolism, which has made the interpretation of some of the
phenotypes related to disruption of the Pta-AckA pathway challenging. Additional
challenges can be attributed to the labile nature of the acyl phosphate bond present
in phospho-Asp modification (1), which has hindered the development of antibodies
capable of detecting phosphorylated RRs and made it difficult to obtain definitive
evidence of an AcP-dependent phosphorylation of RR in vivo.
Relatively recent biotechnological advances have the potential to facilitate
the detection of phosphorylated RRs in vivo and allow for a more definitive test of
the hypothesis that AcP acts as a phosphoryl donor to RRs in vivo. In 2006, Kinoshita
et al. optimized a method to detect phosphorylated proteins by mobility shift assay.
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This method consists of introducing a phosphate-binding tag (Phos-TagTM) bound to
acrylamide beads into SDS-PAGE gels. The Phos-TagTM molecules, with the help of
Zn2+ or Mn2+, preferentially interact with molecules with phosphomonoester bonds
as seen in proteins with phosphorylated Ser, Thr and Tyr side chain residues, slowing the electrophoretic migration of these proteins through a gel (70). In 2008,
Barbieri and Stock utilized phos-tagTM to detect the labile phosphorylation of the E.
coli RR PhoB both in vitro, using purified protein, and in vivo, using cell lysates (5).
Using this methodology, Liu et al. demonstrated that, consistent with the notion that
CpxA function as a phospho-Asp phosphatase in vivo, phosphorylation of Yersinia
pseudotuberculosis CpxR, expressed from a plasmid vector, increased in a cpxA mutant background when compared to the WT parent. This finding corroborates what
has been demonstrated in vitro (36, 111) and proposed in vivo (6, 17, 23, 24, 149).
Liu et al. (2011) also demonstrated that this CpxA-independent phosphorylation required the Pta-AckA pathway, but failed, however, to perform a complete epistasis
analysis (85).
I extended the results of Liu et al (2011) by demonstrating that, in E. coli,
endogenously expressed CpxR becomes phosphorylated in a glucose-dependent
manner independently of the SK CpxA. Using a plasmid-born CpxR, I demonstrated
that the glucose-induced phosphorylation requires the conserved Asp-51 residue. I
also conducted a complete epistasis analysis of the Pta-AckA pathway effect on
glucose-induce CpxR phosphorylation and concluded that this phosphorylation
requires AcP. This conclusion was based on the presence of phosphorylated CpxR

116
when cells accumulated AcP, whereas complete deletion of the Pta-AckA pathway
led to almost undetectable levels of phospho-CpxR. However, I acknowledge the
existence of a weak glucose- and AcP-independent signal exhibited by the pta ackA
double mutant. Currently, we do not know the origin of this weak signal. Perhaps,
under the conditions tested, a small percentage of CpxR is phosphorylated by a noncognate sensor kinase and/or another small phospho-donor.
Lastly, while the use of Phos-TagTM requires some optimization, at the present moment, this is likely the best and most accessible approach to detect phosphorylated RRs in vivo.

PROTEIN ACETYLATION IS AN IPORTANT CONTRIBUTOR
TO cpxP TRANSCRIPTION
In addition to being regulated via CpxA- and/or AcP-dependent phosphorylation, I propose that cpxP activity also is regulated via an N-lysine acetylation.
Exposure to glucose can induce cpxP transcription in a sensor kinaseindependent manner. While one might initially consider the involvement of catabolite repression in glucose-induced cpxP transcription, the observation that both catabolite-repressing and non-catabolite-repressing carbon sources (e.g. glucose and
acetate, respectively) can trigger CpxA-independent cpxP transcription argues
against it. Instead, this finding focused my attention on the alternative hypothesis
that transcription-activating carbon sources contribute to cpxP transcription via an
acetylation event. I base this proposition on the following evidence: (1) growth in
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the presence of excess glucose leads to an increase in the overall protein acetylation
status that can be detected via mass spectrometry analysis and Western immunoblot analysis. (2) exposure to the NAD+-dependent deacetylase inhibitor nicotinamide
induces cpxP transcription in the absence of glucose or other carbon sources, (3)
overexpression of the NAD+-dependent deacetylase CobB inhibits glucose-induced
cpxP transcription, and (4) glucose-induced cpxP transcription specifically requires
the GCN5-like acetyltransferase YfiQ and a lysine residue 298 located on the surface
of the αCTD that, under my tested growth condition, is acetylated in a glucose- and
YfiQ-dependent manner.
Although I demonstrated that glucose-induced cpxP transcription is affected
by CobB and YfiQ, the mechanism behind this effect remains unclear. Exposure to
glucose altered the acetylation status of multiple proteins. This was observed as an
increase in the number and/or intensity of acetylated bands as detected by Western
immunoblot analysis. Glucose also induced a two-fold increase in the number of
proteins and lysines detected to be acetylated by mass spectrometry (B. Schilling, B.
Gibson, and A. J. Wolfe, unpublished data). Unlike glucose, the CobB inhibitor nicotinamide caused relatively few changes in the total acetylation profile, as previously
reported (157). Thus, nicotinamide and therefore CobB inhibition likely exert a
more limited effect on the E. coli acetylome than does glucose. This marginal effect
of CobB on overall protein acetylation was quantified by mass spectrometry analysis. In general, deletion of CobB promoted a 10% increase in overall protein acetylation in the absence of glucose and approximately 20% when the cells were grown in
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the presence of glucose (B. Schilling, B. Gibson, and A. J. Wolfe, unpublished data).
Several factors could contribute to this observation: (1) the deacetylase CobB might
have a limited number of acetylated targets, whereas the additional AcCoA could be
used as an acetyl donor by multiple acetyltransferases; (2) CobB might not be fully
expressed and active when the samples were collected for analysis; and (3) presently unidentified deacetylases could exist (L. I. Hu and A. J. Wolfe, unpublished data).
Under any of these circumstances, inhibition of the deacetylase CobB would not be
expected to exert a large impact on the acetylome. It should be noted, however, that
CobB overexpression antagonized glucose-induced acetylation. This behavior is
consistent with one of three possibilities: (1) CobB could directly reverse glucoseinduced acetylations, (2) CobB could activate another deacetylase(s) that reverses
those acetylations, or (3) CobB could inhibit the acetyltransferase(s) responsible for
those acetylations.
Glucose-induced cpxP transcription requires YfiQ, and YfiQ is required for
approximately 75% of the glucose-induced Lys acetylation on RNAP; however, I was
unable to obtain evidence that YfiQ can directly acetylate RNAP in vitro. This inability to directly acetylate RNAP with YfiQ in vitro makes me favor the possibility that
the YfiQ effect on RNAP acetylation is indirect. Indeed, the Wolfe laboratory possesses evidence that YfiQ inhibits glycolysis, which would diminish the concentration of AcP (A. J. Walker-Peddakotla, M. Kuhn, W. F. Anderson and A. J. Wolfe, unpublished data).
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The pattern of RNAP acetylation is affected by disruption of the Pta-AckA
pathway. One of the key residues under these conditions is α Lys-291. Under
conditions that promote Lys-291 acetylation, cpxP transcription is diminished.
Contrary to what I observed for Lys-298, I found no evidence that YfiQ plays any
role in Lys-291-dependent inhibition of cpxP transcription. Although
overexpression of YfiQ promoted a small increase in glucose-induced cpxP
transcription, it did not alter the weakened response by the ackA mutant. This
weakened response also was unaffected by deletion of yfiQ. Although,
overexpression of several acetyltransferases inhibited cpxP transcription in the WT
parent, deletion of any single enzyme did not permit the ackA mutant to respond
robustly to glucose. A simple explanation for these results is that multiple
acetyltransferases could acetylate Lys-291; however, at this point, I have identified
no acetyltransferase that could acetylate RNAP. Alternatively, Lys-291 could become
acetylated independently of the action of an acetyltransferase. Efforts to distinguish
between these two mechanisms are underway. Indeed, quantitative mass
spectrometry revealed that Lys-291 is hyperacetylated in the glucose-exposed ackA
mutant relative to its WT parent (B. Schilling, B. Gibson, and A. J. Wolfe, unpublished
data).
To date, YfiQ is the only E. coli acetyltransferase with confirmed protein
acetyltransferase activity. However, under the conditions I tested (TB supplemented
with 0.4% glucose), YfiQ only affected the acetylation of approximate 10% of proteins when compared to WT, as detected by mass spectrometry analysis (B. Schil-
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ling, B. Gibson, and A. J. Wolfe, unpublished data). Some of the proteins acetylated by
YfiQ are proteins involved in the switch between glycolysis and gluconeogenesis,
leading to the hypothesis that YfiQ contributes to the regulation of central metabolic
pathways. Indeed, in support to this hypothesis, YfiQ mutants possess a growth defect under certain limiting nutritional conditions, when compared to WT (WalkerPeddakotla, A. J. and Wolfe A. J., unpublished). Changes in carbon sources that are
supplemented into the media can alter the acetylation patterns of more than 100
proteins in both E. coli and Salmonella. This change in acetylation has been proposed
to lead to change in the direction of carbon flux to glycolysis or gluconeogenesis and
control the activity of the glyoxylate shunt relative to the tricarboxylic acid cycle
[reviewed in (132)]. Thus, it is possible that the YfiQ effect on RANP acetylation
could be derived from an YfiQ effect in central metabolism.
The link between central metabolism and YfiQ goes beyond the YfiQ involvement in the acetylation of some metabolic proteins. Recent evidences suggest
that, in E. coli, YfiQ transcription is affected by the concentration of cyclic AMP, linking transcription regulation of this acetyltransferase to central metabolism. It was
proposed that this regulation occurs via CRP, as the putative yfiQ promoter contains
two CRP binding elements that are required for yfiQ transcription (18). In contrast,
in M. tuberculosis, cAMP directly activates the YfiQ homologue Mt-PatA, by binding
to a cyclic nucleotide–binding domain fused to the N terminus of the catalytic PAT
domain (75, 96). Efforts to understand the connection between YfiQ, cAMP, central
metabolism, and protein acetylation are underway.
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AcP-DEPENDENT ACETYLATION
The data presented here support the hypothesis that AcP affects the overall
protein acetylation status of E. coli. RNAP isolated from ackA mutant cells exhibited
a vastly different acetylation pattern than RNAP isolated from the WT parent. A similar observation has been made for RcsB (L. I. Hu and A. J. Wolfe, unpublished data).
On the basis of these observations, anti-acetyl-lysine Western blot and mass spectrometric analyses were performed on an isogenic set of strains that included mutants defective for the Pta-AckA pathway and the known acetylation-associated enzymes (B. Zemaitaitis, B. Schilling, B. Gibson, and A. J. Wolfe). Western blot analysis
provided evidence that AcP is a major regulator of protein acetylation in E. coli.
Whenever AcP levels were increased (i.e., in an ackA mutant grown in TB or in a pta
mutant gorwn in TB supplemented with acetate, or in WT cells grown in TB supplemented with glucose), global acetylation increased. Mass spectrometric analysis
extended and quantified those observations. For example, the number of proteins
detected as acetylated by mass spectrometry analysis was 90% greater in cell lysates from the ackA mutant than from its WT parent. This increase in protein acetylation was observed whether glucose was present or not. Consistent with the notion
that this increase in protein acetylation is an AcP-dependent phenotype, the pta
ackA double mutant exhibited a major decrease in the total number of detected
acetylated proteins to a total of only 60% of the WT level, when the cells were
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grown in the absence of glucose. Finally, Western immunoblot analyses showed that
most of the glucose-dependent acetylation required AcP.
This AcP-dependent increase in detectable acetylated proteins could be explained by a combination of any of the following possibilities: (1) AcP could induce
an increase in the expression and/or activity of an AcCoA-dependent protein acetyltransferase, (2) AcP could function as an acetyl donor for a presently unidentified
acetyltransferase, (3) or AcP could directly transfer its acetyl group to the target
protein.
Whichever the mechanism, initial analyses demonstrate that approximately
7% of total E. coli proteins are acetylated in the ackA mutant. This number jumps to
approximately 12% when the cells are grown in the presence of glucose. This number is likely to be an underestimate as this represents a snapshot of the acetylome as
the cells enter stationary phase. Additionally, due to inherent limitations of the approach used, proteins found in very low concentration may not have been detected
by this mass spectrometry analysis, which would also contribute to an underestimate of the total number of acetylated proteins.
RNAP is among some of the proteins whose acetylation has been shown to be
affected by disruption of the Pta-AckA pathway. This evidence comes from mass
spectrometric analysis of RNAP purified from immunoprecipitation and also from
RNAP that present in cell lysates. Although my results implicated approximately
75% of the acetylation sites on RNAP to YfiQ, my attempts to reconstitute this reaction in vitro with purified proteins have failed. Instead, as detected by Western im-
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munoblot analysis, in vitro acetylation of some RNAP subunits occurred when AcP
was added to the reaction as the acetyl donor. Since I cannot completely discard the
possibility that my purified protein samples could be contaminated with a protein
that uses AcP as an acetyl donor to acetylate proteins, my finding that addition of
AcP to purified RNAP leads to its acetylation lends support to two of the three possibilities presented above: (a) An acetyltransferase could use AcP to acetylate proteins in vivo, or (b) AcP could acetylate these proteins directly. Lastly, it is important
to mention that although I was unable to acetylate RNAP in vitro using AcCoA as the
acetyl donor and YfiQ as the acetyltransferase, I cannot discard the possibility that
this reaction may occur in vivo and that I may have not found the appropriate in
vitro condition to reproduce it.
It remains untested if the AcP-dependent acetylation of RNAP has any effect
on its activity in vivo. While the data I presented here support the hypothesis that
acetylation of Lys-298 and Lys-291 contributes to the regulation of cpxP transcription, I cannot yet say whether the acetyl group for these acetylation events come
from AcCoA or from AcP. Mass spectrometry analysis of in vitro acetylated RNAP is
currently underway to determine if AcP can acetylate either of these residues in
vitro. Independently of where the acetyl groups for acetylation of Lys-298 and Lys291 come from, I did observe an AcP-dependent effect on RNAP activity in vitro,
marked by a progressive decrease in rna1 transcription as the concentration of AcP
in the reaction increased. This effect is likely to be context dependent as AcP had the
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opposite effect on cpxP transcription, leading to a dose-dependent increase in cpxP
transcription.
If AcP can indeed directly acetylate proteins in vivo, one could easily imagine
that if not properly regulated this acetylation could have some negative impact on
overall cellular physiology. One likely candidate to help the cells regulate AcPdependent acetylation is the deacetylase CobB. In an in vitro assay, purified CobB
has been shown to be capable of deacetylating short peptides that had been previously acetylated using AcP as the acetyl donor (M. Kuhn, M. Scholle, M. Mrksich, W.
F. Anderson, A. J. Wolfe, unpublished data). Thus, it is possible that, in a manner parallel to the phospho-Asp phosphatase activity of some SKs, the deacetylase CobB
may help maintain the proper levels of certain acetylated proteins by deacetylating
proteins that have been previously acetylated by AcP. Indeed, evidence from the
Wolfe laboratory supports the hypothesis that CobB deacetylates some AcPdependent lysine acetylations (A. AbouElfetouh, D. Christensen, and A. J. Wolfe, unpublished data).

A ROLE FOR ACETYLATED Lys-298
Following enrichment by immunoprecipitation, mass spectrometry analysis
revealed acetylation of several surface-exposed lysines of the β, β’, and α subunits of
RNAP isolated from WT cells exposed to glucose. Due to its smaller size and the fact
that only two lysines were found to be acetylated, I further investigated the effect of
αCTD acetylation on cpxP transcription. Using a merodiploid system, I asked wheth-

125
er any of the Lys on αCTD played a substantial role in glucose-induced cpxP transcription and found that Lys-298 did. Expression of the K298A mutant inhibited
transcription, whereas similar expression of the other α K-to-A mutants, including
the alanine mutant of Lys-297, which was also found to be acetylated, had no significant effect on glucose-induced cpxP transcription. Furthermore, the requirement for
Lys-298 was specific: extracytoplasmic stimuli that activate CpxA kinase activity and
thus rapid phosphorylation of CpxR did not require Lys-298.
The findings presented here substantially add to data presented by previous
reports that RNAP subunits can become acetylated (155, 157). It also establishes at
least one growth condition under which these acetylation events likely occur and
implicate the acetyltransferase YfiQ in acetylation of the majority of those sites, including Lys-1200 of β, which had been previously reported to be acetylated (157).
However, at this moment it is not clear if YfiQ is a direct or indirect contributor to
these acetylations.
It is also unclear what percentage of α becomes acetylated on Lys-298 under
the conditions tested, since this value has to be obtained by quantitative mass spectrometry methods. However, clues exist to suggest that the majority of α isolated
from glucose-exposed WT cells is acetylated. These clues come from the fact that
trypsin, the protease used to obtain the MS-analyzed peptides, cleaves after lysines
but not after acetyllysines. From glucose-naïve WT cells, we detected the nonacetylated peptides (291-297) TPNLGK and (299-310) SLTEIKDVLASR, suggesting
that Lys-297 and Lys-298 were not acetylated. In contrast, from glucose-exposed
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WT cells, our collaborators detected the related but acetylated peptides (291-298)
TPNLGK297(+42)K and (298-304) K298(+42)SLTEIK, suggesting that Lys-297 and
Lys-298 could be acetylated. Strikingly, the inability to detect the non-acetylated
peptides TPNLGK and SLTEIKDVLASR in glucose-exposed samples suggests that
much of the α isolated from glucose-exposed WT cells is acetylated on Lys-297 and
Lys-298.
How could acetylation of Lys-298 affect cpxP transcription? Analysis of the
crystal structure of CRP and αCTD bound to a synthetic DNA fragment containing
two CRP binding sites flanked by αCTD binding sites suggests that Lys-298 of α
makes direct interaction with DNA adjacent to the CRP binding site (7). Thus, Lys298 likely plays a role in closed complex formation, the first step in transcription
initiation. So how could acetylation of Lys-298 work? While I cannot definitively answer how acetylation of Lys-298 contributes to cpxP transcription, it is possible that
non-acetylated αCTD binds to a site that is not conducive to CpxR-dependent activation. If so, the acetylation of Lys-298 could re-position the αCTD, permitting it to
make productive contact with CpxR. Alternatively, CpxR and RNAP could form an
overly stable complex that binds tightly to the cpxP promoter. If so, then acetylation
of Lys-298 might loosen this interaction, facilitating promoter clearance. Whichever
mechanism is true, it should be noted that although Lys-298 is required for glucoseinduced cpxP transcription, it may not be sufficient; other acetylated lysines on the
surface of the other RNAP subunits might also participate. Additionally, Lys-298 is
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not required for CpxA-dependent activation of cpxP, suggesting a distinct activation
mechanism.
Other questions remain: What are the general rules for activation? How general is the effect of Lys-298 acetylation? Does protein acetylation influence transcription from other CpxR-dependent promoters? Does it influence CpxRindependent promoters? There is evidence that the response to glucose and other
carbon sources is context-dependent, i.e. some CpxR-dependent promoters respond
to carbon source exposure and some do not (A. Cosgrove, B. P. Lima and A. J. Wolfe,
unpublished data). This context-dependence suggests that the mechanism(s) by
which acetylation influences transcription is not simple, and may involve factors
such as promoter architecture and nucleoprotein complex composition.

A ROLE FOR ACETYLATED Lys-291
The acetylation profile of α isolated from the cpxA ackA mutant differed from
the acetylation profile of α isolated from its WT parent. Thus, it appears that RNAP
can become acetylated on multiple lysine residues on different subunits and that the
acetylation pattern of RNAP can differ depending on genetic background and growth
condition. While one α acetylation was common to both strains, five acetylations
were specific to the cpxA ackA mutant including Lys-291, which had been shown by
other to be acetylated (ref), and only one was specific to WT (i.e., Lys-298). The genetic screen conducted here suggests that Lys-291 is definitely involved in weakening the response to 0.4% glucose by the ackA mutant or to 4.0% glucose by its WT
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parent. I currently do not possess definitive evidence that acetylation of Lys-291
causes these behaviors; however, support for such a mechanism is provided by the
dramatic reduction in glucose-induced cpxP transcription by the K291Q mutation,
which is predicted to exhibit properties that mimic acetylated Lys-291 (25). While
the underlying molecular mechanism remains to be determined, it is distinctly possible that Lys-291 acetylation could affect one of the many interactions made by α
and, as a result, decrease the stability of the transcription complex. Lys-291 is located on the αCTD helix-hairpin-helix motif, which is reported to contribute to both
nucleic acid binding and protein-protein interaction (117). To the best of my
knowledge, no evidence exists that Lys-291 makes direct contact with DNA. In contrast, Lys-291 has been reported to make direct contact with activation region 2 of
the transcription antiterminator NusA (116). Furthermore, Lys-291 is located near
the 287 determinant, an αCTD surface known to make direct contact with the catabolite activator protein (CAP, also known as CRP) [reviewed in (14)]. Although no direct evidence exists for an αCTD-CpxR interaction, our report that the αCTD is required for glucose-induced cpxP transcription (83) hints that an interaction between these two proteins might exist, perhaps in manner similar to that reported
for OmpR, another member of the winged-helix-turn-helix family of response regulators [reviewed in (67)].
Using the well-characterized CRP-αCTD interaction as a guide, we hypothesize that Lys-291 might participate in an interaction between CpxR and the αCTD. If
so, then the acetylation of Lys-291 could affect this interaction and therefore impact
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transcription. Efforts are underway to identify the mechanism by which Lys-291
and its acetylation affect cpxP transcription.

MODEL
I envision a simple model that accounts for all the observations presented
here. When a cell grows in buffered TB, the lack of a strong extracytoplasmic stimulus permits CpxA to function as a net phosphatase, removing phosphoryl groups
from phospho-CpxR. If that cell becomes exposed to a carbon source (e.g. glucose,
pyruvate, lactate or acetate) whose metabolism results in an increase in intracellular AcP concentration, then the increased AcP concentration leads to phosphorylation of certain RRs (including CpxR) and to acetylation of more than 10% of total E.
coli proteins, including proteins that comprise RNAP. If metabolism of that carbon
source (e.g. glucose or lactate) also requires an NAD+-dependent enzyme (e.g.
glyceraldehyde dehydrogenase or lactate dehydrogenase, respectively), then a competition might ensue with the NAD+-dependent deacetylase CobB for the limited
supply of NAD+. This competition would result in reduced deacetylation of CobB targets. The result would be a dramatic increase in the acetylation of certain proteins,
including many that regulate transcription.
YfiQ influences the pattern of RNAP acetylation; however, the mechanism
remains unknown. One possibility could be that a YfiQ-dependent effect on carbon
flux through central metabolism could influence AcP concentration, and thus lead to
changes in the acetylation pattern of RNAP. Distinct acetylation sites on RNAP could
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differentially impact its activities, including its ability to bind to promoters and to
interact with transcription factors. The outcome of RNAP acetylation at the level of
cpxP transcription seems to be either activation (if Lys-298 is acetylated) or inhibition (if Lys-291 is acetylated).
Several important questions remain unanswered. Does YfiQ directly acetylate RNAP and does this acetylation affect cpxP transcription. How does AcP affect
the overall pattern of protein acetylation? Do acetyltransferases exist that can utilize
AcP as the acetyl donor? Does the in vitro acetylation of RNAP by AcP represent a
situation that occurs in vivo? CobB impact on overall protein acetylation seems to
have been modest. Is this a clue that other unidentified protein deacetylases exit in
E. coli? What is the overall transcriptional impact of RNAP acetylation?
In summary, I propose that AcP can function as a phosphoryl donor to CpxR,
both in vitro and in vivo and an acetyl donor to RNAP at least in vitro and probably in
vivo. The output of this multiple modification, at the level of the cpxP promoter,
seems to be modulation of the strength of cpxP transcription. My work suggests that
acetylation of Lys-298 somehow contributes to promoter activity, whereas acetylation of Lys-291 dampens this activation.

CONCLUDING REMARKS
Great strides have been made to understand the role of protein acetylation in
eukaryotes. In contrast, our knowledge of protein acetylation in bacteria remains in
its infancy. Our current knowledge is restricted to three lists of acetylated bacterial
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proteins, the structures of several bacterial GNATs, some functions of a single
acetyltransferase (YfiQ/Pat), a single deacetylase (the NAD+-dependent sirtuin
CobB), and the effects of acetylation on the functions of three acetylated proteins
that function in central metabolism, chemotaxis [reviewed in (53)] and RNA metabolism (80, 81). The data presented here extends that knowledge by (1) implicating
AcP as a major determinant in controlling protein acetylation, (2) showing that several RNAP subunits can become acetylated on multiple lysines, and (3) demonstrating that the protein acetylation machinery of E. coli affects transcription of at least
one promoter, potentially by its ability to modify RNAP, the molecular machine that
performs transcription of all bacterial genes.
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Table 1
Strain and plasmid Table
Strain
PAD282

Relevant Characteristic
F- araD139 Δ(argF-lac)U169
rpsL150(Strr) relA1 flhD5301 deoC1
λΦ(PcpxP'-lacZ)

Source/Reference
(30)

PAD292

PAD282 cpxR1::spc (spectinomycin insertion in cpxR with polar effect on
cpxA)

(30)

PAD348

PAD282 cpxA::cam

DiGuiseppe & Silhavy
(Princeton University)

AJW2790

PAD282 ackA::kan

(149)

AJW2791

PAD282 Δ(ackA pta)::cam

(149)

AJW2794

PAD282 cpxA::cam ackA::kan

(149)

AJW3143

PAD282 yfiQ::kan

(83)

AJW3827

PAD292 ackA::kan

(84)

AJW3875

PAD292 Δ(ackA pta hisJ hisP dhu)
zej223::Tn10

(84)

AJW3167

PAD282 ΔcpxA::kan

(84)

AJW3994

PAD282 ΔackA::frt

(83)

AJW4303

AJW3994 ΔtmcA::kan

(84)

AJW4304

AJW3994 ΔypeA::kan

(84)

AJW4305

AJW3994 ΔyedL::kan

(84)

AJW4306

AJW3994 Δaat::kan

(84)

AJW4307

AJW3994 ΔyhbS::kan

(84)

AJW4308

AJW3994 ΔyafP::kan

(84)

AJW4309

AJW3994 ΔyiiD::kan

(84)

AJW4310

AJW3994 ΔrimJ::kan

(84)

AJW4311

AJW3994 ΔrimL::kan

(84)

AJW4312

AJW3994 ΔyiaC::kan

(84)

AJW4313

AJW3994 ΔyjhQ::kan

(84)

AJW4314

AJW3994 ΔspeG::kan

(84)

AJW4315

AJW3994 ΔargA::kan

(84)
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AJW4316

AJW3994 ΔrimI::kan

(84)

AJW4317

AJW3994 ΔyhhY::kan

(84)

AJW4318

AJW3994 ΔphnO::kan

(84)

AJW4319

AJW3994 ΔyjdJ::kan

(84)

AJW4320

AJW3994 ΔyjaB::kan

(84)

AJW4321

AJW3994 ΔwecD::kan

(84)

AJW4322

AJW3994 ΔyjgM::kan

(84)

AJW4333

AJW3994 ΔyncA::kan

(84)

AJW4867

PAD282 ΔcpxA::kan ΔackA::frt

P1:JW3882 → AJW3994
(KmR)

AJW1939

ackA::kan

(73)

AJW2013

Δ(ackA pta hisJ hisP dhu) zej223::Tn10

(148)

JW2293

ΔackA::kan

(2)

JW3882

ΔcpxA::kan

(2)

Plasmid
pCA24n

Relevant Characteristics
Control plasmid (CmR)

Source/Reference
(71)

Plasmid expressing 6xHis-CpxR under
pCA24n-cpxR the control of an IPTG-inducible promoter (CmR)

(71)

pCA24ncpxRD51A

Plasmid expressing 6xHis-CpxRD51A
under the control of an IPTG-inducible
promoter (CmR)

(84)

pBPL001

pET-28 derivative expressing 6xHisCpxR under the control of an IPTGinducible promoter. (KnR)

(84)

p770-cpxP

p770 derivative expressing cpxP promoter (ApR)

Unpublished

pCA24n-yfiQ

Plasmids expressing 6xHis-yfiQ under
the control of an IPTG-inducible promoter (CmR)

(71)

pCA24n-yiiD

Plasmids expressing 6xHis-yiiD under
the control of an IPTG-inducible promoter (CmR)

(71)

Plasmids expressing 6xHis-atoB under
pCA24n-atoB the control of an IPTG-inducible promoter (CmR)

(71)
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pCA24nargA

Plasmids expressing 6xHis-argA under
the control of an IPTG-inducible promoter (CmR)

(71)

pCA24n-elaA

Plasmids expressing 6xHis-elaA under
the control of an IPTG-inducible promoter (CmR)

(71)

pCA24nyjgM

Plasmids expressing 6xHis-yjgM under
the control of an IPTG-inducible promoter (CmR)

(71)

pCA24n-yjaB

Plasmids expressing 6xHis-yjaB under
the control of an IPTG-inducible promoter (CmR)

(71)

pCA24nyhhY

Plasmids expressing 6xHis-yhhY under
the control of an IPTG-inducible promoter (CmR)

(71)

pCA24n-rimJ

Plasmids expressing 6xHis-rimJ under
the control of an IPTG-inducible promoter (CmR)

(71)

pCA24n-yjdJ

Plasmids expressing 6xHis-yiid under
the control of an IPTG-inducible promoter (CmR)

(71)

pPHB1

pGEM-T-Easy derivative expressing
phbCAB+ (Apr)

(83)

pPHB2

pTAC-85 derivative expressing
phbCAB+ (Apr)

(83)

pREII

Plasmid expressing WT rpoA or alanine
substitution derivatives (ApR)

(39)

pREIIrpoAK10A

pREII derivative expressing rpoAK10A

(84)

pREIIrpoAK25A

pREII derivative expressing rpoAK25A

(84)

pREIIrpoAK95A

pREII derivative expressing rpoAK95A

(84)

pREIIrpoAK271A

pREII derivative expressing rpoAK271A

(39)

pREIIrpoAK291A

pREII derivative expressing rpoAK291A

(39)

pREII-

pREII derivative expressing rpoAK297A

(39)
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rpoAK297A
pREIIrpoAK298A

pREII derivative expressing rpoAK298A

(39)

pREIIrpoAK304A

pREII derivative expressing rpoAK304A

(39)

pREIIrpoAK291R

pREII derivative expressing rpoAK291R

(84)

pREIIrpoAK291Q

pREII derivative expressing rpoAK291Q

(84)
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Table 2.
The number of acetylated  and ’ peptides detected from ackA mutant cells 1

Beta (Glucose-exposed)
Total Spectra
(R)EAPEGTVk115(+42)DIK(E)
(R)QLEk279(+42)DDVK(L)
(K)LSQSGHk331(+42)R(I)
(R)Sk639(+42)GESSLFSR(D)
(R)AVAVDSGVTAVAk719(+42)R(G)
(R)DTk844(+42)LGPEEITADIPNVGEAALSK(L)
(K)VTPk890(+42)GETQLTPEEK(L)
(R)AIFGEk909(+42)ASDVK(D)
(K)ASDVk914(+42)DSSLR(V)
(R)ALEIEEMQLk954(+42)QAK(K)
(R)AVLVAGGVEAEk988(+42)LDK(L)
(K)LDk991(+42)LPR(D)
(R)k1035(+42)ITQGDDLAPGVLK(I)
(R)IQPGDk1065(+42)MAGR(H)
(R)HGNk1073GVISK(I)
(K)INAmLk1133(+42)QQQEVAK(L)
(K)QQQEVAKk140(+42)LR(E)
(R)k1178(+42)GMPIATPVFDGAK(E)
(K)ELLk1200LGDLPTSGQIR(L)

Replicate Replicate Replicate
1
2
3
366
382
305
1
0
0
1
1
0
0
0
1
0
1
1
1
0
0
1
0
0
1
1
1
1
1
1
1
1
1
1
1
0
2
1
1
1
0
0
0
1
1
1
0
0
0
1
1
1
2
2
1
1
1
1
2
2
0
1
0
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Beta' (Glucose-exposed)
Total Spectra
(K)AQTk13(+42)TEEFDAIK(I)
(R)GLATTIk395(+42)AAK(K)
(R)ITEYEk557(+42)DANGELVAK(T)
(K)TSLk570(+42)DTTVGR(A)
(R)AAAESSIQVk953(+42)NK(G)
(K)GSIk959(+42)LSNVK(S)

1Red,

Replicate
1
314
1
1
1
1
0
1

Replicate
2
248
1
1
0
1
1
1

acetylated peptides detected in at least two biological replicates;
Black, acetylated peptides detected in one biological replicate; m, oxidized
methionine, M, methionine; k, acetylated lysine; K, lysine.
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Table 3.
ACETYLATED  PEPTIDES FROM ackA MUTANT CELLS1.

1
2

Green, unacetylated peptides; Red, acetylated peptides
m, oxidized methionine; M, methionine; k, acetylated lysine; K, lysine
3 Supplemental Table in which the raw data is presented
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TABLE 4

Table 4. Immunoprecipitated β and β′ proteins were separated by SDS-PAGE and β
and β′ bands were digested with trypsin, as described (20). The resulting peptides
were analyzed in a LTQ OrbitrapXL mass spectrometer, as described in the experi-
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mental procedures section and analyzed using the Scaffold software. The table
shows the Xcorr, DCn scores, charges, both the observed precursor m/z and actual
peptide mass, and the mass deviation (delta ppm) of all 15 K-acetylated peptides
detected for b and 11 Lys-acetylated peptides detected for β′ in the glucose-exposed
samples.
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